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Abstract 
Psychosocial factors affecting Quality of Life in Motor Neuron Disease 
Noah John Granger 
Motor neuron disease is a neurodegenerative condition that disrupts the motor system, causing 
progressive disability and ultimately resulting in death. Death is usually caused by respiratory 
paralysis within 2-4 years from symptom onset, and within this time quality of life is of the 
utmost concern. Despite the intuitive idea that the main driver for a decline in quality of life 
would be the decline in patients’ physical function and the ensuing loss of independence, 
studies do not support this – indeed, the evidence indicates that psychosocial factors may be of 
more importance when it comes to global quality of life. The most examined factors are 
depression, anxiety, and social factors, but due to the multiple scales used to measure these 
factors and to measure quality of life, a consensus has not been reached on their significance.  
This study aimed to examine psychosocial factors and quality of life in the TONiC cohort. The 
study found significant associations between disability and depression, hope and anxiety, 
physical function and social withdrawal, and quality of life subdomains and social withdrawal. 
Non-significant associations were found between demographics, time from diagnosis and 
depression, and locus of control subscales and anxiety. The three main factors - depression, 
anxiety and social withdrawal - were all found to have significant associations with global quality 
of life in this cohort.  
The importance of these findings lies in creating a greater awareness of the importance of these 
factors in motor neuron disease, as well as using the associations to identify individuals at risk of 
depression, anxiety, withdrawal or poor quality of life. Additionally, the findings can be used to 
prompt investigation into possible interventions for these factors. Due to the cross-sectional 
nature of this data the direction of effect between factors cannot be identified; accordingly, 
longitudinal studies are required to identify the direction of effect, and also to identify change in 
the relative importance of various psychosocial factors over time. 
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Systematic review of psychosocial factors 
affecting quality of life in motor neuron 
disease 
Introduction 
Motor neuron disease (MND) is a chronic degenerative neurological condition. Estimates of 
incidence vary, with a commonly quoted paper reporting it at around 1.5-2.5 per 100,000 per 
year in Europe and the US1 whereas a UK based study found it to be higher at 2.6 per 100,000 
per year in women and 3.9 per 100,000 per year in men2. It occurs at any age in adulthood and 
the lifetime risk in the UK is estimated at 1 in 350 in men and 1 in 472 in women2, although the 
male preponderance decreases with increasing age, and above 70 the male to female ratio 
approaches 1.3 
MND has several subtypes, depending on the pattern of disease. These include Amyotrophic 
Lateral Sclerosis (ALS), Progressive Muscular Atrophy (PMA), Progressive Bulbar Palsy (PBP) and 
Primary Lateral Sclerosis (PLS).4 It can also be divided into sporadic and familial cases which 
make up 90-95% and 5-10% of cases respectively.5  
Increasing loss of cortical, bulbar and ventral cord motor neurons means that these diseases are 
progressively disabling and ultimately fatal, usually due to respiratory failure. Average survival is 
2-4 years from symptom onset, although a small proportion of the population survives for more 
than a decade.6 
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Previously considered a purely motor disease, non-motor aspects of MND are increasingly 
recognised and being researched.7 Cognitive deficits and a link with frontotemporal dementia 
(FTD) were first suggested decades ago.8,9,10,11 However, due to the nature of these complaints, 
patients may not have insight12,13 regarding cognitive symptoms, such that screening is 
required.14 A more recent paper gives a description of an ALS-plus syndrome, and in its 
definition gives the possible additional features of “dementia, geographic clustering, 
extrapyramidal signs, objective sensory loss, autonomic dysfunction, cerebellar degeneration, or 
ocular motility disturbance.”15  
Unfortunately, only one disease modifying treatment is available, riluzole, and this is described 
as exerting only a modest neuroprotective effect.4 This disease’s characteristics and lack of 
treatment options means that Quality of Life (QOL) is a significant concern for patients, carers 
and healthcare staff. QOL is a complicated area for these patients; due to the heterogeneity of 
presentation, uncertain aetiology and poor prognosis of the disease, a wide variety of factors 
could impact on QOL in MND, and discovering these factors has been the focus of some 
research in recent years.   
Simmons16  originally concluded that there was no consensus on which measures to use when 
looking at MND. They stated that historically “SIP and SF36 etc” were used, but as health-related 
quality of life (HRQOL) measures they are heavily skewed towards physical function, and would 
decline with disease progression regardless. More global QOL (GQOL) measures were then 
developed, including the WHOQOL instruments, as well as the McGill QOL questionnaire, 
SEIQOL and SEIQOL-DW measures. 
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Despite the intuitive idea that the drastic decline in physical function would be the driver for 
reducing QOL there is some evidence to the contrary. In 2000, Simmons et al17 showed in a 
prospective study that QOL as perceived by the patient did not correlate with measures of 
physical function. The finding that QOL may relate to factors other than physical function led to 
the suggestion that the McGill QOL (MQOL) scale may be more appropriate for measuring QOL 
than other scales (SIP/ALS-19) as it considers both physical and mental health-related factors, as 
well as non-health-related factors including existential and spiritual factors. Another prospective 
study a year later reached a similar conclusion regarding physical function’s non-relatedness.18 
In 2002 a cross-sectional study looked at an abbreviated, self-generated measure of QOL (the 
Schedule for Evaluation of Individual Quality of Life-Direct Weighting (SEIQOL-DW)) and found 
that, despite 64.5% of the sample nominating health as an important QOL-related category, 
there was no correlation between SEIQOL-DW and either the ALS severity score (ALSSS) or SIP 
scores.19 There was, however, evidence for correlation with emotional support and cognitive 
difficulties. Another cross-sectional study looked at both the SEIQOL-DW and MQOL and again 
found that physical status was not significant for QOL and that self-perceived quality of social 
support was the most important explicatory variable for both QOL scales.20  
Neudert, Wasner and Borasio, showed that HRQOL is not necessarily correlated with GQOL.21 In 
their study the SIP and SF-36 (health-related measures) had no correlation with the SEIQOL-DW 
(a GQOL measure).21 In an earlier study of theirs, the validity, as rated by 42 ALS patients, of the 
SEIQOL-DW was rated higher than that of the SIP (p<0.001) and that of the SF-36 (p<0.001), 
suggesting that patients may find  GQOL measures more representative of their experience than 
HRQOL measures.22  
The suggestion by Simmons et al that GQOL measures should be adopted in preference to 
HRQOL measures has not been universally conformed to. However, this idea is key; as the above 
studies show that not only does a decline in physical function not cause the expected reduction 
in QOL but, further to this, QOL relates to how an individual experiences their life, not how they 
experience their health. GQOL measures are required for an accurate representation of the lived 
experience of MND patients. 
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In 2013, Gibbons et al23 aimed to create a Structural Equation Model (SEM) that could explain a 
large degree of the variance seen in QOL and in depression when looking at a cross-sectional 
sample of 147 MND patients. It was found that functional status, as measured by the 
Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS), did not correlate with QOL or 
with fatigue, but it did mildly correlate with depression. However, QOL was found to correlate 
most strongly with depression, meaning that an indirect link could be made between functional 
status and QOL, through its effects on depression. 
As well as discovery that MND patient’s QOL may not always decline with physical deterioration, 
it also seems that their QOL may in fact be better than the general population and even 
caregivers would think.24,25 These findings are in line with another study examining multiple 
conditions across multiple cultures, suggesting that society may have a flawed perspective when 
it comes to ill health and QOL.26 This has required a change in professional and caregivers’ 
perceptions of how patients respond to their condition. To try to explain these findings, the idea 
of response shift has been proposed, wherein the changing circumstances of the patient may 
force re-evaluation of values and a shift in attitudes and internal standards which impact on 
QOL.27 This is seen in various ways in MND. For example a patient’s meaning in life becomes 
found more in “family and friends, the act of giving and receiving help, the feeling of having a 
life of their own and accepting the present” as well as their perspective being such that 
“material things and quarrels were no longer in focus”.28 When MND patients were asked to 
identify the factors affecting their QOL, one study found the most common and most important 
cues chosen were family/significant other as well as religion, recreation, hobbies, friends, 
entertainment, leisure activities, and social life.16 A qualitative study, looking at coping, 
identified “cognitive reappraisal, reframing, and intellectual stimulation as coping mechanisms; 
the development of wisdom; and the vital importance of interpersonal relationships” as key 
themes.29 A study of biographical disruption and repair identified emphasis on “finding new 
meaning and restoring normality.”30 These overlapping and related concepts in the above 
studies support the notion of a ‘response shift’ in MND patients and how this may limit the 
disease’s impact on their QOL. 
17 
 
As to whether there is unmet need for psychosocial intervention in the MND population, a team 
in Oslo investigated patient satisfaction with their treatment and found that patients were least 
content with the psychological help they received, and with the information given to their 
relatives.31 The qualitative papers mentioned above are by no means an exhaustive survey, but 
do give us an idea of why psychosocial factors are of such importance in MND, and the 
relevance of further evaluating these to guide clinical care. 
Better understanding of the experience of MND patients also has a more general relevance. 
Noel Conway is a 67-year-old gentleman with MND who is the most recent person to challenge 
the law in England and Wales on assisted suicide.32 The High Court case, the first after MPs 
rejected a change in the law in 2015, demonstrates some of the arguments for and against. The 
subject is an emotive one, and this is demonstrated by the passionate arguments made by each 
side. Baroness Jane Campbell, a prominent disability equality advocate, is of the opinion that a 
change in the law could change perspective such that disabled individuals are devalued in 
society. Mr Conway’s argument relates to his decline in QOL in as much that he feels he has 
been condemned to “unimaginable suffering.” He wishes to have a medically assisted death at a 
time of his choosing. The key issue, that may be considered as somewhat separate, is that he 
believes in his right to die and in having control over the manner of his death, thus it may not be 
a loss of QOL that drives this desire but a loss of autonomy. 
This is supported by Ganzini et al who found that physicians’ opinions of patients with a wish for 
hastened death were that they were determined, independent individuals who were concerned 
with becoming a burden, and with loss of control.33 The physicians assessed these patients for a 
mood disorder but did not find that they were depressed and suggested that these patients 
“viewed living as purposeless and too effortful, and that they were ready for death.” 
In their study, Albert et al found that, after requesting a hastened death, patients’ suffering 
decreased and their ratings of control increased, reinforcing the notion that wish to die is 
predominantly an issue of autonomy and avoiding future suffering, and not necessarily an 
indication of depression or of a drastically poor QOL at that time.34 
This should remind the reader that despite the surprisingly positive findings about the QOL of 
MND patients as a cohort, individuals can still suffer greatly, and the impact of the disease 
should not be underestimated. 
18 
 
  
19 
 
Method: 
Aim: Identify psychosocial factors which have been studied regarding their effect on QOL in 
MND. 
Identification of studies 
Databases: Medline, Scopus, Web of Science, CINAHL, The Cochrane library, PsycINFO, 
AMED, BNI, EMBASE 
Types of study: Journal article 
Time span: No limit 
Languages: Full article must be available in English 
Title/Abstract search for: 
"Motor neuron disease" OR "Motor Neurone Disease" OR “MND” OR “M.N.D.” OR 
"Amyotrophic Lateral Sclerosis" OR “ALS” OR “A.L.S.” OR "Lou Gehrig’s" OR "Lou Gehrig" OR 
"Lou Gehrigs" OR "motor neuron diseases" OR "motor neurone diseases" OR "Anterior horn cell 
disease" OR "Charcot disease" OR "Charcot's disease" OR "Charcots disease" OR "Primary Lateral 
Sclerosis" OR “PLS” OR “P.L.S.” OR "progressive muscular atrophy" OR “PMA” OR “P.M.A.” OR 
"Progressive Bulbar Palsy" OR “PBP” OR “P.B.P.” 
AND 
"Quality of life" OR “QOL” OR "Q.O.L." OR "Life quality" 
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A Population Intervention Comparator Outcome (PICO) system was used initially to generate the 
domains to be used. Population was considered as MND/ALS, intervention was psychosocial 
factors but this was only considered later, no comparator was used and the outcome was QOL. 
The population and outcome keywords were searched in the various databases to retrieve 
studies for short listing. The choice of databases was based on what investigators thought would 
give the most relevant and comprehensive yield for the research question as well as MEDLINE 
and EMBASE being recommended by the Cochrane handbook on systematic reviews35 (although 
this is aimed more towards clinical trials). The National Institute for Health and Care Excellence 
(NICE) Healthcare Databases Advanced Search (HDAS) was used to search AMED, BNI, CINAHL, 
EMBASE, MEDLINE and PSYCHinfo. These databases were searched individually through NICE 
HDAS as it was discovered by the researchers that combining results with boolean operators 
does not work when using multiple databases, and that using the thesaurus to ‘explode’ search 
terms is not the same across the respective databases. Therefore, for the population parameter 
a fixed set of keyword phrases was searched for in title and abstracts or equivalent fields in each 
database with the addition of ‘motor neuron disease’ and ‘amyotrophic lateral sclerosis’ being 
‘exploded’ in each database to include ‘narrower terms’. For the outcome parameter, the same 
method was applied with fixed keywords searched across all databases with ‘quality of life’ 
being ‘exploded’ in each database individually. Using AND to connect the population and 
outcome for each database then generated results that could were exported to the referencing 
software. 
Search keywords were changed or removed if errors occurred when combining results. This 
seemed to happen with the keywords which contained periods e.g. “A.L.S.” or those that 
produced zero results. Between the original search and a later re-run to identify new results the 
NICE HDAS website was updated. The performance of the search engine was much improved 
and the issues detailed above requiring removal of search terms were no longer apparent. 
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The Cochrane database (Reviews and CENTRAL) only allows a limited number of keywords so 
“Quality of Life” AND “Motor Neuron disease” OR “Amyotrophic Lateral Sclerosis” were 
searched in title, abstract and keywords. For MND and ALS there were dropdown options to 
select when searching, in order to ensure word variations are searched, although it remains 
uncertain what these variations were. The resulting papers could not be exported en masse as a 
.RIS file compatible with the referencing software (only as a .txt) so the shortlisting of papers 
was done on the database with only those selected being exported to the referencing software. 
In SCOPUS ‘Articles and reviews’ were searched using the previous terms as a string using the 
advanced search functions. In Web of Science the search terms were also entered as a string. 
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Databases 
NICE HDAS Cochrane 
SCOPUS 
Web of 
Science AMED BNI CINAHL EMBASE MEDLINE PSYCH info Reviews CENTRAL 
Fields searched Titles and Abstracts 
Title, Abstracts and Keywords 
Title, 
Abstracts 
and 
Keywords Topic 
Problem/Population 
Motor Neuron Disease          
Motor Neurone Disease          
MND          
M.N.D.          
Amyotrophic Lateral 
Sclerosis          
ALS          
A.L.S.          
Lou Gehrig's          
Lou Gehrig          
Lou Gehrigs          
Motor Neuron Diseases          
Motor Neurone Diseases          
Anterior Horn Cell Disease          
Charcot Disease          
Charcot's Disease          
Primary Lateral Sclerosis          
PLS          
P.L.S.          
Progressive Muscular 
Atrophy          
PMA          
P.M.A.          
Progressive Bulbar Palsy          
PBP          
P.B.P.          
           
Additional Info 
Thesaurus 
terms for 
'motor 
neuron 
disease' and 
'amyotrophic 
lateral 
sclerosis' 
exploded 
Thesaurus 
term for 
'motor 
neuron' 
disease was 
instead 
'motor 
neurone 
disease' 
which was 
exploded, no 
thesaurus 
terms found 
for 
'amyotrophic 
lateral 
sclerosis' 
Thesaurus 
terms for 
'motor 
neuron 
disease' and 
'amyotrophic 
lateral 
sclerosis' 
exploded 
Thesaurus 
terms for 
'motor 
neuron 
disease' and 
'amyotrophic 
lateral 
sclerosis' 
exploded 
Thesaurus 
terms for 
'motor 
neuron 
disease' and 
'amyotrophic 
lateral 
sclerosis' 
exploded 
No 
thesaurus 
term for 
'motor 
neuron 
disease' 
Thesaurus 
term 
'amyotrophic 
lateral 
sclerosis' 
was 
exploded 
"Motor 
neuron 
disease" and 
"Amyotrophic 
Lateral 
Sclerosis" 
looked up as 
MESH terms 
and exploded 
"Motor 
neuron 
disease" and 
"Amyotrophic 
Lateral 
Sclerosis" 
looked up as 
MESH terms 
and exploded 
Entered as 
string* 
Entered as 
string** 
Population results 1053 309 6523 119982 92398 105053 
22 cochrane 
reviews + 16 
other 354 183,507 88802 
                      
Outcome 
Quality of Life          
QOL          
Q.O.L.          
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Table 1.1 Table to show the different search strategies for each database. 
Screening and eligibility 
Screening:  
Results were evaluated by title and abstract for exclusion of irrelevant results and assessed for 
quality by the primary researcher. Those of uncertain value had the full article read. Those still 
of uncertain value were read by a second researcher. Any studies selected for inclusion by the 
primary researcher were also read by a second researcher. Disagreement resulted in discussion 
between the two researchers. Reference lists of any review articles were checked to look for 
studies missed by the literature search.  
Eligibility:  
Peer reviewed papers (conference abstracts, editorials and letters not eligible) on psychosocial 
factors which can be defined and measured in patients, for example by published outcome 
measures, available in English were included.  Studies analysing factors which cannot be altered 
by clinical care, such as personality or economic hardship were excluded. Qualitative papers 
describing patient effects that could not be defined in a reproducible way were excluded, such 
as 'the pervasive impact of an awkward and unreliable body' (Brott et al. 2007)36. Papers linking 
psychosocial factors with QOL according to opinion rather than patient-derived data were 
excluded. Treatment modalities, eg music therapy, CBT, meditation, and trial protocols were 
excluded. Studies where participants with MND could not be separated for analysis or were not 
commented on distinctly from other conditions were excluded. 
Life quality          
Additional info 
thesaurus 
term for 
'Quality of 
life' 
exploded 
Health and 
Quality of 
Life 
exploded 
thesaurus 
term for 
'Quality of 
life' 
exploded 
thesaurus 
term for 
'Quality of 
life' 
exploded 
thesaurus 
term for 
'Quality of 
life' 
exploded 
thesaurus 
term for 
'Quality of 
life' 
exploded 
"Quality of 
life" looked 
up as MESH 
term and 
exploded 
"Quality of 
life" looked 
up as MESH 
term and 
exploded 
Entered as 
string* 
Entered as 
string** 
Outcome results 11445 92512 74813 436757 242921 52565 
242 cochrane 
reviews + 912 
other 16214 309139 266249 
Population AND Outcome 
Overall results 82 106 375 2398 1255 781 
2 cochrane 
reviews + 2 
other 24 trials 1547 1174 
                      
*Entered as string TITLE-ABS-KEY(("Motor neuron disease" OR "Motor Neurone Disease" OR MND OR “M.N.D.” OR "Amyotrophic Lateral Sclerosis" OR ALS OR “A.L.S.” OR "Lou Gehrig’s" OR "Lou 
Gehrig" OR "Lou Gehrigs" OR "motor neuron diseases" OR "motor neurone diseases" OR "Anterior horn cell disease" OR "Charcot disease" OR "Charcot's disease" OR "Charcots disease" OR 
"Primary Lateral Sclerosis" OR PLS OR “P.L.S.” OR "progressive muscular atrophy" OR PMA OR “P.M.A.” OR "Progressive Bulbar Palsy" OR PBP OR “P.B.P.”) AND ("Quality of life" OR QOL OR "Q.O.L." 
OR "Life quality")) 
**TS=(("Motor neuron disease" OR "Motor Neurone Disease" OR MND OR M.N.D. OR "Amyotrophic Lateral Sclerosis" OR ALS OR A.L.S. OR "Lou Gehrigs" OR "Lou Gehrig" OR "Lou Gehrigs" OR 
"motor neuron diseases" OR "motor neurone diseases" OR "Anterior horn cell disease" OR "Charcot disease" OR "Charcot's disease" OR "Charcots disease" OR "Primary Lateral Sclerosis" OR PLS OR 
P.L.S. OR "progressive muscular atrophy" OR PMA OR P.M.A. OR "Progressive Bulbar Palsy" OR PBP OR P.B.P.) AND ("Quality of life" OR QOL OR "Q.O.L." OR "Life quality")) 
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In sorting, reviews on MND were classified as wrong study type, as they may have had findings 
related to psychosocial factors, but would only be citing studies which should have been 
identified by the literature search. Of the final selection of promising results some were found to 
be conference abstracts with no full paper available and these again were classified as wrong 
study type. 
During shortlisting in Microsoft Excel, six results were lost on 6/10/16 due to the programme 
crashing, but as these had already been sorted in the referencing program no included results 
were lost. 
 
Figure 1.1 Flowchart showing breakdown of results and exclusion. 
Results of the systematic search 14,17,20,23,37–64 
Factors identified by quantitative studies included:  
 Mental-health factors: Depression, anxiety. 
 Social factors: Social support, social withdrawal, social isolation, speech 
disturbance/communication issues, sense of burden, satisfaction with relationships, 
dyadic cohesion, less social anxiety, the support subscore of MQOL. 
•3291 wrong 
topic
•173 wrong 
study type
•20 wrong 
participants
3533 
results
•12 conference 
abstracts only
•4 full article 
not available 
in english
•Poor quality 2
50 
results
Used for 
systematic 
review
32 
results
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 Coping strategies: Coping, confiding/emotional support, problem management coping 
stategy, emotional avoidance coping strategy, cognitive appraisal, protective buffering, 
emotional role functioning, venting, positive reframing, disengagement, mindfulness. 
 Mood/feeling states: Feelings of worthlessness or helplessness, happiness, positive self-
perception, hopelessness, confusion-bewilderment, loneliness, boredom, 
embarrassment, wondering why to keep going, anger, worry, less rumination. 
 Other: Religiosity, conservation values (security, conformity, tradition), lack of freedom, 
psychological and existential subscores of MQOL. 
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Figure 1.2 Graph showing the number of studies that investigated a particular factor. 
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Figure 1.3 Graph showing, for each factor, the number of QOL measures with which a significant 
positive, significant negative or non-significant relationship was found. 
Those factors related to more than one measure of QOL have been represented in the graph 
below. This shows the proportion of the studies for each factor showing significance versus non-
significance. 
0
5
10
15
20
25
30
35
40
N
um
be
r o
f Q
O
L 
m
ea
su
re
s
Studies showing positive, negative or no 
relationships
Number of measures of QOL with significant positive relationship
Number of measures of QOL with significant negative relationship
Number of measures of QOL with no significant relationship
28 
 
 
Figure 1.4 Graph showing, for factors measured more than once, the proportions of studies (out 
of 100%) that demonstrated significant positive or significant negative versus non-significant 
relationships. 
QOL measures used more than once were turned into the following graphs: 
 
Figure 1.5 Graph showing factors’ relationships to QOL as measured with SEIQOL. 
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Figure 1.6 Graph showing factors’ relationships to QOL as measured with SEIQOL-DW/Index. 
 
 
Figure 1.7 Graph showing factors’ relationships to QOL as measured with MQOL. 
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Figure 1.8 Graph showing factors’ relationships to QOL as measured with MQOL-SIS. 
 
 
Figure 1.9 Graph showing factors’ relationships to QOL as measured with WHOQOL-BREF. 
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Figure 1.10 Graph showing factors’ relationships to QOL as measured with EQ-5D. 
 
 
Figure 1.11 Graph showing depression’s relationships to QOL as measured with SF-36 subscales. 
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Figure 1.12 Graph based on the data from Mora et al, showing factors’ relationships to QOL as 
measured with subscales of the ALSAQ-40.53  
The study by Mora et al53 examined factors that were statements from the emotional reactions 
(EMO) subscale of the ALSAQ-40 and compared these with all subscales of the ALSAQ-40 – 
physical mobility (MOB), activities of daily living and independence (ADL), eating and drinking 
(EAT), Communication (COM), and emotional reactions (EMO). 
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The results from thematic or narrative studies were: 
Study Themes identified as related to QOL 
Foley et al - Perceptions of quality of life in 
people with ALS: effects of coping and health 
care.41 
Importance of faith 
Search for control 
Importance of dignity 
Desire to maintain identity 
Importance of family 
A sense of loss 
Importance of altruism and support 
Fighting amyotrophic lateral sclerosis 
Appreciation of life 
Trail et al - Major stressors facing patients 
with amyotrophic lateral sclerosis (ALS): a 
survey to identify their concerns and to 
compare with those of their caregivers.61  
Existential concerns 
Worry about illness progression 
Worry about dependency 
Worry about loved ones’ well-being 
 
Lule et al - Depression and quality of life in 
patients with amyotrophic lateral sclerosis.48 
“ALS patients were significantly more likely to 
name friends and social environment as 
determinants of their quality of life than were 
the normal control subjects” 
Hecht et al - Subjective experience and 
coping in ALS.44 
At T1 psychosocial factors named as most 
important were: 
“reduction of speech” 
“knowledge of poor prognosis” 
“becoming dependent on other persons”  
At T2 these were the unchanged with the 
addition of “social isolation” 
Table 1.2 Factors identified in thematic or narrative studies. 
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Discussion 
The findings of the systematic review indicated that the majority of the studies were 
quantitative. Of the 28 quantitative studies, the most studies focussed on depression, anxiety 
and social support. Some other factors were examined more than once, such as religiosity, sense 
of burden, social withdrawal and hopelessness, but many factors were only examined once. The 
four qualitative studies reinforced the importance of existential, spiritual, psychological and 
social factors. 
Overarching critical appraisal of the studies 
Many checklists are available for critically appraising quantitative observational studies 
identified by a systematic review such as the CASP (Critical Appraisal Skills Programme) checklist 
for cohort studies, CASP checklist for case control studies65, Newcastle-Ottawa scale66, and 
STROBE (Strengthening the Reporting of Observational studies in Epidemiology) checklist67.  
Out of these options, the quantitative studies identified in this review could have been 
evaluated using the STROBE checklist, as it is the checklist recommended by the British Medical 
Journal (BMJ).67 
Due to time restrictions (on corrections), it was not possible to formally check all 28 quantitative 
studies using the STROBE criteria, however, 10 studies were checked (first ten when ordered 
alphabetically by authors) and the general patterns seen in those studies were that: 
The ten studies appraised were good at providing an informative and balanced summary in the 
abstract, explaining the scientific background and rationale for the study, and presenting key 
elements of the study design early in the paper. As much of the research was considered to be 
exploratory by the authors, specific objectives were not always given past investigating the 
relationship between a given variable/variables and QOL, and, even when more specific 
objectives were given, there may not have been “prespecified hypotheses”. Some may feel that 
this is adequate for these types of studies, considering the scarcity of previous studies, but the 
papers by Ganzini et al42 and Fegg et al39 are good examples of specific objectives, and the study 
by Bremer et al37 is a good example of both specific objectives and prespecified hypotheses, 
which future authors may wish to consult in order to emulate their clarity. 
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Study design was not always indicated in the title or abstract and this is something that could 
easily become uniformly conformed to as awareness and use of checklists (such as STROBE) 
becomes more commonplace when designing/reporting studies as opposed to only when 
critically appraising them. 
The studies explained the sources of data and methods of assessment well, including the 
handling of quantitative variables in the analyses. Eligibility criteria was often brief “definite or 
probable ALS according to the El Escorial revised criteria”, sometimes precluding those with 
cognitive deficit or overt FTD. The latter point is important as it may impact on patient reported 
outcomes and so whether these patients were included or not should be clarified. That is not to 
say that those with cognitive impairment should not be investigated – as they make up a 
substantial minority of MND patients – but this should be specified in the method to aid 
interpretation. 
Some of the studies provided detailed description of the setting, locations, and relevant dates, 
including periods of recruitment but many only commented that a certain number of patients 
were recruited from a neurology centre without including the dates. This also meant that 
numbers of participants at each stage (potentially eligible, examined for eligibility, confirmed 
eligible, agreed to participate) were not always reported although with some of the methods – 
consecutive patients at MND clinic or a retrospective study using a previously acquired cohort – 
this may not have been entirely appropriate. Where numbers of participants at the different 
stages were reported, reasons for non-participation were only given as far as ‘not eligible’, and 
‘declined to participate’, but, reasons for declining participation were not given. This is 
understandable, as it can be difficult to elicit these responses within the ethical framework of 
research. 
Gibbons et al23 is a paper that clearly showed how they had arrived at the study size using 
statistical methods to achieve a desired power, unfortunately this was not common to other 
papers in the review as they appeared to use more ‘opportunistic’ sampling. For the same 
reason, analytic techniques for taking account of the sampling strategy were not considered. 
However, the statistical methods to examine the desired variables were usually described well. 
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Most of the ten studies did not undertake sensitivity analysis so item 12e “describe any 
sensitivity analysis” was not applicable but the study by Bock et al14 did use sensitivity analysis in 
order to determine whether there were any differences between those with complete data for 
forced vital capacity (FVC) and those without complete data for FVC. However, it does not 
appear that this was reported in the results. 
Aside from the example given above, missing data was rarely touched on and this is an area that 
could be improved upon using tables to indicate the numbers of participants with missing data, 
as well as whether and how missing data were addressed. 
Demographic and clinical characteristics were described well, allowing an understanding of the 
types of cohorts that were reported on. 
Results were mostly well reported with regards to Pearson product moment correlation 
coefficients, F - statistics, t - values, beta coefficients, and p – values. Reporting of precision, in 
the form of confidence intervals was less common. A good example of conforming to item 16a 
“give unadjusted estimates and, if applicable, confounder adjusted estimates and their precision 
(eg, 95% confidence interval). Make clear which confounders were adjusted for and why they 
were included” would be the study by Bock at al14 which included tables with all of these details. 
The studies were good at giving “a cautious overall interpretation of results” and summarised 
their key results. Whether results were summarised in reference to study objectives mostly 
depended on whether the study had given specific objectives and/or hypotheses. In terms of 
generalizability, Clarke et al38 and Felgoise et al40 are good examples of studies that mentioned it 
specifically – cautioning against premature generalization – but most others either commented 
on and compared their results to previous studies or didn’t explicitly mention generalizability at 
all. 
The limitations of the studies were often not discussed (although Bock et al14 is a good example 
of discussion of limitations) and, related to this, item 9 “describe any efforts to address potential 
sources of bias” was often ignored aside from some studies comparing the descriptives of their 
cohort when considering selection bias. Similarly, sources of funding were difficult to comment 
on in some papers as they was not mentioned, and so it may have been that they received no 
funding or that the information was simply omitted. 
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To surmise, improvements could have been made by: clarifying the study design in the title or 
abstract; providing more detailed description of the setting of the studies, dates between which 
recruitment took place, and numbers of participants at each stage; describing how sample sizes 
were arrived at; and discussing the limitations of the studies and how potential bias may have 
affected the results. However, whilst this incomplete analysis gives an idea of some of the 
problems that may have been found in the studies included in this systematic review, it should 
be treated with caution as not all studies have been assessed this way. 
Similar to the quantitative studies, there are multiple checklists for use in evaluating qualitative 
studies, such as the CASP checklist for qualitative studies65 and SURE (Specialist Unit for Review 
Evidence) checklist68. The four qualitative studies in this review were examined using the CASP 
checklist65 for qualitative studies and performed moderately well. All four studies had a “clear 
statement of the aims”, although the study by Lule et al48 could have been more explicit when 
compared to the others. Qualitative methodology was appropriate considering the aims. Design, 
recruitment and data collection mostly seemed appropriate to the aims but were not justified 
clearly in the text by the studies’ respective authors. In terms of recruitment the study by Trail 
et al61 acknowledged that it was limited by its cohort being restricted to those with the 
“'motivation, means, and family support to attend an ALS specialty clinic' - typically not 
ventilator dependent and strong enough to travel, although they may need mechanical 
assistance for ambulation.”. With respect to data collection, saturation was not discussed by any 
of the studies. Similarly, it was not clear whether “the relationship between the researcher and 
participants” had been adequately considered as it was not mentioned in any of the four 
studies. All studies except that by Hecht et al44 stated their approval from an ethics committee. 
Analysis was rigorous but there could be greater examination of the role of the researcher, 
potential bias, and how this may have affected the results of the study. There was a “clear 
statement of the findings” for all four studies but they did not appear to discuss the “credibility 
of their findings (e.g. triangulation, respondent validation, more than one analyst)”. Due to the 
scarcity of studies in this area, these studies were valuable in exploring the subjective 
experience of some patients, with MND with both Foley et al41 and Hecht et al44 doing well to 
consider their findings in the context of previous studies. 
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CASP item 
Foley et al - 
Perceptions 
of quality 
of life in 
people 
with ALS: 
effects of 
coping and 
health 
care.41 
Trail et al - 
Major 
stressors 
facing 
patients 
with 
amyotrophic 
lateral 
sclerosis 
(ALS): a 
survey to 
identify 
their 
concerns 
and to 
compare 
with those 
of their 
caregivers.61  
Lule et al - 
Depression 
and quality 
of life in 
patients 
with 
amyotrophic 
lateral 
sclerosis.48 
Hecht et al 
- 
Subjective 
experience 
and coping 
in ALS.44 
Clear 
statement of 
the aims Yes  Yes Yes  Yes 
Was 
qualitative 
method 
appropriate Yes Yes Yes  Yes 
Was the 
design 
appropriate 
to address 
the aims 
Yes- not 
justified 
Yes - not 
justified Can't tell 
Yes - not 
justified 
39 
 
Was the 
recruitment 
stategy 
appropriate 
to the aims 
Yes – Not 
justified Yes 
Yes – Not 
justified 
Yes – Not 
justified 
Was data 
collected in a 
way that 
addressed 
the research 
issue Yes  Can't tell Yes Yes  
Has the 
relationship 
between the 
researcher 
and 
participants 
been 
adequately 
considered No No No No 
Have ethical 
issues been 
taken into 
consideration Yes  Yes  Yes  Can't tell 
Was data 
analyisis 
sufficiently 
rigorous Yes Can't tell Yes  Yes 
Is there a 
clear 
statement of 
the findings Yes  Yes  Yes  Yes  
40 
 
How valuable 
is the 
research Valuable Valuable Valuable Valuable 
Table 1.3 table to show an evaluation of the qualitative studies identified by this review using the 
CASP checklist for qualitative studies. 
Quality of Life 
An overarching limitation of the studies pertinent to this review is how QOL is measured. 
When looking at the results of the literature search, it was worth considering whether HRQOL 
had been used as opposed to GQOL, as HRQOL measures are limited in the ways described 
earlier. The contradictory findings identified by the systematic review may be due to whether 
HRQOL or GQOL measures were used, as HRQOL measures are not a comprehensive assessment 
of MND patients’ experience and Neudert, Wasner and Borasio explain that there may be no 
association between HRQOL and GQOL measures.21 For example, depression was seen to 
correlate with the WHOQOL-BREF (a global measure) but not with the SIP (a health-related 
measure). 
Nonetheless, GQOL measures have limitations too, for example the MQOL is not disease specific 
so may not be sensitive to ALS specific factors such as loss of communication. Additionally, 
Felgoise et al found that the SEIQOL-DW is “of great value in identifying those factors which 
contribute to the psychosocial well-being of an individual with ALS”, but that it may not be as 
appropriate for measuring aggregate QOL in a group of ALS patients.69  
Scales used for psychosocial factors 
As well as multiple measures being used for QOL, multiple measures were used for many of the 
psychosocial factors. Again, this could cause confusion due to the different properties of the 
scales, as discussed later for depression specifically. 
Meta-analysis 
Different measures used in the various studies for both QOL and psychosocial factors, as shown 
in the table below, mean that, despite multiple papers on certain factors, any useful meta-
analysis is not possible. 
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Factor Measured with Quality of life measure 
compared to 
Depression GDS, ZDS, HADS, HADS 
modified for MND, DSM-IV, 
BDI, BDI with somatic 
components removed, CES-
D, ADI-12, Depression-
Dejection subscale of POMS-
SF, ‘I have felt depressed’ 
statement from emotional 
subscale of ALSAQ-40, 
Hamilton depression score, 
PHQ-9, MCS of SF-36. 
MQOL, MQOL-SIS, SEIQOL, 
SEIQOL-DW, SIP (possibly 6 
point Likert scale instead), 
WHOQOL-BREF, Subscales 
of SF-36, Psychological 
wellbeing subscale of 
MQOL, SF-12 MCS, SF-36 
MCS, Subscales of ALSAQ-
40g 
Endicott QOL enjoyment 
and satisfaction 
questionnaire, 
EQ-5D, EQ-VAS. 
Anxiety HADS, STAI, Tension-Anxiety 
subscale of POMS-SF. 
SEIQOL-DW, WHOQOL-
BREF, SF-12 MCS, Endicott 
enjoyment and satisfaction 
questionnaire, MQOL. 
Social support SSQ, The Duke UNC 
functional social support 
questionnaire, F-SozU K-14, 
BSSS. 
SEIQOL-DW, MQOL, MQOL-
SIS, SIP (possibly 6 point 
Likert scale instead, EQ-5D. 
Religiosity Idler Index of religiosity. MQOL, MQOL-SIS, SEIQOL-
DW, SIP/ALS19. 
Hopelessness The hopelessness scale by 
Beck and Weissman, 
‘I have felt hopeless about 
the future’ statement from 
emotional subscale of 
ALSAQ-40. 
SIP (possibly 6 point Likert 
scale instead, Subscales of 
ALSAQ-40. 
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Sense of burden Three items from the Zarit 
Burden Inventory, 
‘I have worried I am a 
burden to other people’ 
statement from emotional 
subscale of ALSAQ-40. 
SIP (possibly 6 point Likert 
scale instead, Subscales of 
ALSAQ-40. 
Social withdrawal SWS, SWSMND. MQOL-SIS, WHOQOL-BREF. 
Confiding/emotional support. CPQ, Brief COPE. SEIQOL-DW, SF-36. 
Problem management coping 
strategy 
MNDCS. SEIQOL-DW. 
Emotional avoidance coping 
strategy 
MNDCS. SEIQOL-DW. 
Cognitive appraisal MNDCS. SEIQOL-DW. 
Speech 
disturbance/communication. 
Speech item of ALSFRS, 
communication subscale of 
ALSAQ-40. 
ALSSQOL, emotional 
subscale of ALSAQ-40. 
Table 1.4 Table to show measures used when a factor was studied more than once. 
Specific papers 
The study on pseudobulbar affect (PBA)70 met the inclusion criteria at screening but was 
excluded after review of the full-text due to quality, as it had a low number of MND participants 
for both their PBA (n=19) and control (n=4) groups and stated that, when using their planned 
method of a t-test, these sample sizes were too low to produce a reliable result. 
The paper by Cardol et al met the inclusion criteria at screening but was excluded after review of 
the full-text due to the low sample number of fifteen patients and the use of a general question 
with a 5-point scale for experienced QOL.  
Sexual relationships and behaviour 
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In the literature search, there were some studies focusing on sexual relationships/behaviour and 
MND and these found some dysfunction and dissatisfaction.71,72,73 Unfortunately, no studies 
investigated the direct effect of sexual issues on QOL. It is to be hoped that it is not the socially 
taboo nature of this topic that has resulted in the scarcity of articles, and that this factor will be 
examined more closely in future. 
 
Issues to consider when investigating some psychosocial factors in MND 
Temporal relationships 
Before discussing some of the psychosocial factors identified in this review, it is worth 
mentioning the finding that different factors vary their influence over time. Some factors may 
not be important soon after diagnosis, but become a strongly influential factor later in the 
disease course.50,53 This is a theme that is touched on again later in various chapters. 
Depression 
A large proportion of the studies reviewed examine depression in MND and its effect on QOL. 
These studies use ordinal scales, some of which distinguish ‘caseness’. However, in the case of 
inferential statistics the results will not distinguish between depressive symptoms and 
depressive illness. This is not without merit but readers should be aware that conclusions from 
these studies cannot be applied without consideration. As these findings will relate to both 
depressive illness and ‘sub-threshold’ depression, the research will not guide clinicians as to 
what level of depressive symptoms would benefit from interventions. 
Multiple scales are used to measure depression, and, depending on which is used, a different 
prevalence rate is identified in MND patients. There is a prevalence in the range of 9-11% when 
using the DSM-IV criteria but up to 44% when using other criteria.74 
44 
 
Some frequently used depression measures have limitations in an MND population. The study 
by Koerner et al, for example, uses the Beck depression inventory but notes its disadvantages in 
a physically disabled group such as MND, due to the somatic items in the measure. They 
measured the BDI’s correlation with subscales of the SF-36 both with and without these somatic 
items, but unfortunately only give the p-values for their findings with the unchanged BDI.46 In 
MND patients there may be very different findings when investigating depression depending on 
whether measures are self-reported or completed by another person. Depression is 
overestimated by healthy subjects asked to comment on virtual patients and by caregivers 
compared to what patients report.24,25,75 Caregiver’s perspectives were not considered in this 
review, but these findings do indicate a skewed social perspective in comparison to how 
individuals with MND perceive themselves. 
One of Lule et al’s papers acknowledges that the DSM-IV clinical interview looks at both the 
momentary affective state and any history of earlier depressive episodes whereas the measure 
they used, the ADI-12, only looked at self-reported momentary affective state. They commented 
that this may have made the ADI-12 less specific and may have found markedly higher rates of 
depression.48 One study uses the Geriatric depression scale; it could be questioned as to 
whether this is appropriate for an MND cohort.14  
Interventions for depression, such as medication and psychotherapy, which may be 
implemented early, due to general recommendations of early recognition and intervention in 
chronic diseases such as this, may affect findings. 
Depression and anxiety and QOL worsening over time was shown in a repeated measures 
study76 of 40 patients with ALS (PALS) and their caregivers over a year. The authors postulated 
that due to the progressive nature of the illness, it was advancement of the physical illness that 
caused the decrease in all their analysed constructs. They did however state that it is important 
to offer psychological and sometimes psychiatric support.  
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There are however many studies that have found no increase in depression over time58,77, or as 
death approaches78. In fact in Salas T et al’s study the “Deepest feeling of depression” was found 
to occur more frequently close to the time of diagnosis.79 Therefore this could be a time for 
increased vigilance and intervention. To fully understand the relationship between depression 
and time, several confounding factors would need analysis. One may hypothesise whether 
speed of progression over time affects levels of depression, or whether it is changes in coping 
styles that affect when depression is most prevalent in certain cohorts. 
Studies recognised factors found to affect depression in MND such as delayed diagnosis80, 
physical function (as measured by the ALSFRS-R and Norris scale)81, anxiety63, mindfulness55, 
negative social support82, and certain coping strategies83,84,49,44. These additional factors should 
be further investigated as they may be targeted to reduce depression and improve QOL.  
Similar to this is the idea that other predictive factors for depression could be investigated in 
order to identify individuals at greatest risk. Some factors found to be associated with 
depression include gender, employment status, perceived health status and ALS type85 as well as 
educational status48. 
 
 
Social isolation/support 
The importance of social support is mentioned in multiple studies, and the related factors of 
social isolation and withdrawal were also identified by the review. At least one study suggests 
that there can be a difference between perceived social support and received social support49, 
and therefore the interventions for these may be different, as simply providing more support 
may not necessarily increase perceived support. There are likely to be many factors influencing 
social support, withdrawal and isolation. These include depression86 as well as relationships with 
older age (reduced social functioning)46 and, as discussed later, communication (more sources of 
support)87 and religiosity (increased support)37. This emphasises the need to examine multiple 
factors at a time if possible, as focusing on one factor’s direct effect on QOL leaves the vast 
interplay of a multitude of factors unexamined. 
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As was stated for depression, non-modifiable factors (such as age) may help predict who is likely 
to require more social support, and modifiable factors (such as communication) can be targeted 
for improvement by healthcare teams. 
Communication 
Two quantitative studies40,5340 examined the ‘direct’ effect of communication loss and many 
more examined interventions to improve communication including eye tracking and 
Augmentative and Alternative Communication (AAC)88–96,97. In the study included in this review 
it was shown that a decline in communication ability was associated with decrease QOL40, but it 
remains to be seen whether this is an independent factor or whether a plethora of associated 
psychosocial factors such as social isolation92, self-esteem, self-image, anxiety, autonomy93 are 
affected by communication, and whether it is these factors that mediate the effect on QOL. 
On this note, one narrative study found that "Users of computer communication reported more 
sources of support and happiness and less frustration from difficulty expressing themselves."87 
In terms of both communication and social support a developing field of increasing significance 
is the use of social media for and with patients, and it will be interesting to see how this 
develops.98 
 
 
 
Religiosity/spirituality 
Religiosity and religion was identified as a factor in this review and it is worth mentioning some 
difficulties when investigating this factor. There is a diversity of definitions, which includes 
deciding whether to separate it from spirituality (sometimes defined as an existential awareness 
and belief in a higher force without the doctrine of organized religion).  
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Due to these definitional issues, it is difficult to assess whether one study is comparable to 
another. Aside from this is the issue as to whether to consider it a trait or a coping 
mechanism99,100. Additionally, the location of the study must always be borne in mind, as the 
cultural significance of religion will vary depending on geography, and thus the results are not 
generalizable to the global MND population. Bremer et al acknowledge that in areas with other 
religious individuals the social relations that come with public religiosity may provide additional 
support.37 These authors found that religiosity showed a trend to strengthen its relationship 
with QOL over time. 
Pseudobulbar affect 
Aside from the study on Pseudobulbar affect (PBA) mentioned earlier in this review and 
excluded due to quality there were additional studies investigating how interventions for PBA 
increased QOL. However, some of these interventions may have affected other factors, such as 
the use of antidepressants affecting the key factors of depression and anxiety, such that we 
cannot be certain whether it is the decrease in PBA symptoms that causes the increase in QOL. 
Nonetheless, it is important to acknowledge that this is a factor that can be influenced with 
pharmacological management.101–104  
An interesting finding with pseudobulbar affect was that it was not always reported to clinicians 
depending on which emotions were present. The combination of crying and anger was far less 
likely to be reported than the combination of labile laughing and anger.105 Neither of these 
combinations were reported 100% of the time and future work may focus on encouraging 
patients to feel comfortable reporting pseudobulbar affect, although some may simply not find 
it troubling. 
A finding that may support pseudobulbar affect impacting patients negatively was that 
emotional lability may increase anxiety106, however it should be acknowledged that the 
evidence for anxiety affecting QOL is conflicting. 
 
Limitations of the systematic review 
Gold-standard 
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It was required from a time and resource perspective that the full article must be in English. This 
is less than the gold standard for systematic reviews and resulted in some studies not being 
included in the review. 
Another limitation of the method was that the grey literature was not searched and again this is 
less than the gold standard for systematic reviews. For example, a study on locked in syndrome 
(LIS) by Lule et al107 commented on unpublished data by Zickler which found that LIS MND 
patients named family, friends, social contact and social environment as determinants of their 
QOL more frequently than controls. It also commented on unpublished data by Häcker finding 
that patients perceiving social support rated their QOL as significantly higher when compared to 
those not perceiving social support. This highlights that unpublished literature may have further 
informed this review. 
Critical appraisal 
It is unfortunate that, due to limited time during corrections it was not possible to assess each 
quantitative study using the STROBE checklist. Therefore, the findings of the limited analysis of 
ten studies should be interpreted with caution. 
Structure 
Upon reflection, it is clear that the structure and overall quality of this systematic review would 
have been improved by using a tool such as the PRISMA 2009 checklist108 to ensure accurate and 
uniform reporting, particularly with respect to statement of principal summary measures, risk of 
bias in individual studies, risk of bias across studies, describing study selection, and describing 
study characteristics. 
Factors not reviewed 
It is worth mentioning, as part of the overall limitations of this review, some other factors which 
were not included in the scope of this review. 
 
 
Physical 
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The improvement in QOL seen with some interventions for physical factors may be due in part 
to improving psychosocial factors, for example the embarrassment associated with 
sialorrhea.109,110 Without examining physical factors in this review, the full extent of the effect of 
psychosocial factors may go underestimated. 
Conversely psychological factors may influence physical factors such as depression increasing 
pain interference with daily life111 and fatigue being influenced by psychology and personality 
type112. Clearly a holistic approach to MND patients, as is already advocated, is warranted. 
Caregivers 
A lot of literature which discusses the interplay between various patient factors and caregiver 
burden, with particular focus on the significant effects of the behavioural and cognitive 
symptoms of MND.113,114 Some studies look at the association between caregiver’s experience of 
burden and QOL115 and between caregiver burden and patient’s desire for euthanasia116. 
Despite the obvious importance of these factors, to adequately cover psychosocial factors from 
the perspective of the carer would be beyond the scope of this review; accordingly results of 
this study only included patient-rated relationship factors such as ‘sense of burden’ and 
‘satisfaction with relationships’. However, it is important to acknowledge that without 
considering the caregiver’s perspective, the  interplay of patient-caregiver factors is significant. 
Other areas 
Concepts related to QOL, such as meaning in life and wish to die, are obviously important to 
consider, particularly in this patient group, however they are not considered in this review. 
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Conclusion 
Despite many studies, evidence regarding the exact relationship of psychosocial factors to QOL 
remains limited. This is predominantly due to: 
 Lack of agreement on the definition of psychosocial factors. 
 Multiple measures used for measurement of psychosocial factors. 
 Multiple measures used to assess QOL. 
 Studies not using GQOL measures. 
However, available evidence indicates that psychosocial factors do impact on patients’ 
experience of MND and their QOL. Thus, it is essential that further research continues to explore 
psychosocial factors as this will have implications for therapeutic intervention. 
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TONiC study, the TONiC cohort and 
selected factors 
The TONiC study 
The TONiC (Trajectories of Outcome in Neurological Conditions) study began in 2012 with the 
aim of capturing the experience of patients with long term neurological disability, namely 
multiple sclerosis, MND, traumatic brain injury (TBI), spinal conditions, first stroke and 
neuromyelitis optica (NMO). For the purpose of this chapter the following information will be 
specific to the MND aspect of the study. 
TONiC is a multi-centre study, currently with 27 sites for MND. These are co-ordinated by the 
TONiC team at The Walton Centre NHS Foundation Trust. The TONiC lead/Chief Investigator is 
Professor Carolyn Young. 
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Figure 2.1 Map of sites involved in the MND aspect of the TONiC study. 
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Funding 
TONiC has been supported financially by a number of organisations, including: 
 The Walton Centre NHS Foundation Trust 
 The National Institute for Health Research 
 The Motor Neuron Disease Association 
 Biogen Inc. 
 Novartis International AG 
 Merck & Co., Inc. 
 Roche Holding AG 
 Teva Pharmaceutical Industries Ltd. 
 Genzyme Corporation. 
Objectives 
The objectives, as identified in the research protocol, are: 
 To develop a biopsychosocial model of factors affecting QOL in different neurological 
conditions. 
 To examine the validity of the model over time. 
 To develop scales that measure different aspects of QOL in neurological illnesses, where 
generic scales are not available.  
 To test the validity of some existing generic measures. 
Phases 
The first phase of the study began with in-depth interviews with patients to identify themes and 
items to be used in the measures. The themes and items were appraised by an expert panel 
which included both clinicians with expertise in the relevant fields and patient representatives. 
The protocol stated that items that were reasonable and had face validity were then considered 
by two focus groups. One composed of professionals and one of patients.  
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Cognitive debriefing was used in a small trial group of patients invited to face to face interviews. 
This identified gross problems with wording or item dysfunction as well as assessing for the 
applicability, relevance, comprehensibility, and completeness of the draft questionnaire 
(including all the draft scales). A separate group of patients were asked about the ease of use of 
the scales and any other difficulties when using them. There were additional specific questions 
about measures anticipated by the researchers to be problematic. 
For the MND aspect of the study 26 participants took part in individual interviews and 14 
participants took part in focus groups. The groups had mean ages of 63.4 (range 37-84) and 62 
(range 37-74), gender proportions of 61% male and 64% male, and illness duration ranges of 1 
month - 141 months and 5 months – 141 months respectively. For the interviews 50% of 
participants had limb onset MND and a mean ALSFRS-R score of 29.9, the remaining half had 
bulbar onset MND with a mean ALSFRS-R of 38.6. The ALSFRS-R is a revised version of the 
ALSFRS, a tool for evaluating functional status. It has 12-items that make up three domains: 
‘motor function’, ‘bulbar function’ and ‘respiratory function’. Overall, it can be said that a wide 
range of participants was consulted to inform this qualitative phase. 
The results suggested that four core factors for QOL emerged: 
1. Perceived illness prognosis 
2. Sense of self 
3. Significant others 
4. Life to enjoy 
As well as three influential factors for people to maintain their QOL post-diagnosis: 
1. Influential others 
2. Cognitive attitude 
3. Flexibility 
The following phases (two, three and four) are running concurrently (to facilitate consenting for 
all phases), and are all ongoing. 
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In phase two, demographic data is collected. Clinical care and research teams identify potential 
participants, provide information and obtain informed consent. Demographic data is taken from 
the clinical notes and includes data such as diagnosis, year of diagnosis, type of onset (limb, 
bulbar, respiratory) and ALSFRS-R. 
Phase three is the cross-sectional phase of the study. A large sample of consenting participants 
are recruited to complete the questionnaire pack, which contains the chosen disease specific 
scales and comparison generic scales. A pre-paid envelope is supplied with the questionnaire 
pack for its return, and the option of a secure web-based questionnaire pack is available. A small 
number of participants complete a smaller questionnaire 2-4 weeks later to assess the test-
retest reliability of several questions from the original pack. 
Phase four is the longitudinal phase of the study, it requires participants to have completed 
phases two and three. Following new consent, participants will receive a shortened 
questionnaire pack and pre-paid envelope at months 4, 9, 14, 18, 27, 36 and 60 with a ±2 
months window. In keeping with the idea of ‘responsive autonomy’117, participants will be asked 
at each of these points if they wish to continue to take part in the study. Fortunately, if only 
three or four data points are complete these can still be used for some form of statistical 
analysis. Newsletters will be sent to participants to inform them of the progress of the study. 
Initially phase four was only open to participants who had been diagnosed within the last year. 
This was to ensure that there were robust systems in place to conduct the longitudinal aspect of 
the study. However, investigators and participants were of the opinion that more could be 
gained if this restriction was lifted and as of substantial amendment 8, phase four is now offered 
to all participants who have completed phase three. 
Scales 
Many of the scales used have been assessed psychometrically with classical test theory, but as 
part of the TONiC study some instruments have been subjected to Rasch psychometric analysis 
to assess their scaling properties and internal construct validity.118–120 Analysis of differential 
Item Functioning, within the framework of the Rasch measurement model, was used to test 
invariance of the scales for variables such as age, gender and clinical subtypes of MND. 
Spearman’s rho was used to assess external construct validity. Test-retest reliability was also 
assessed using Spearman’s rho as well as Rasch analysis and Cohen’s kappa. 
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The TONiC cohort 
For the following chapters of this thesis the statistical analysis will be derived from a patient 
sample of 465 participants.  
 
Figure 2.2 Image to show demographic and disease-specific data of this sample. 
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It is important to consider what selection biases may be present in a questionnaire based study. 
In terms of the psychosocial factors to be examined, one may hypothesise whether those with 
high levels of depression, anxiety or social withdrawal – particularly if impairing daily functioning 
– are less likely to attend clinics and if they do whether they are less likely to agree to be part of 
research. Answering these questions would require investigation of non-attendance at clinics as 
well as reasons for research refusal (within ethical approval). The measures of depression, 
anxiety, and social withdrawal had low numbers of missing data at 15, 15 and 0 respectively, 
showing that, for those who agreed to take part in the research, participants were likely to find 
the scales acceptable.  
One may also consider whether patients with low levels of hope would consider research such 
as this futile and decline engagement. In this thesis, hope had the largest number of missing 
data entries out of all the factors examined, at 214 entries. This suggests that for those who 
agreed to participate in the research, there were difficulties in completing this scale. Qualitative 
research would be required to investigate the reasons for this, which are likely to be scale 
design or difficulties with the concept. 
Of the demographic factors considered, perhaps those still in employment are likely to be 
under-represented as they may not attend clinic as much as those no longer in employment. 
Those who are not married or cohabiting may be under-represented as they may find it harder 
to access the assistance required to visit clinics and to complete the questionnaire. Those with 
preserved functioning and thus high ALSFRS-R scores may be less likely to attend clinic as they 
have fewer problems but equally those who are severely disabled, with low ALSFRS-R scores, 
may find it difficult to complete the questionnaire and may not deem it a priority for them when 
they need to be considering how to manage their energy levels and time. However, during data 
entry there were comments more than once that disabled individuals valued this research in 
terms of exploring their concerns and wished to encourage further research to continue to 
interact with them. Those of older age or longer disease duration may similarly feel that their 
time is better spent in other ways. 
Without an obligatory census of the MND population with complete data the best we can hope 
for is a good spread of demographics and disease characteristics to capture a wide-ranging 
sample and then compare this to previous studies. 
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The number of respondents is of an adequate size to be a wide-ranging sample of the UK MND 
population which is estimated to be around 5000 individuals at any one time.121 The mean age 
of 64.9 is similar to a mean age of 65.2 found in a Italian study of 377 patients.122 
As previously mentioned a male preponderance is to be expected in MND populations and this 
sample’s proportions of male and female gender participants are close to a 2011 UK based study 
(56.6% male: 43.4% female) of 830 patients2 as well as being similar to a number of other 
European studies.122,123,124  
Disease duration is difficult to compare to other studies as they often record symptom duration 
from diagnosis or disease duration until death. With the latter, the results are longer than the 
mean disease duration given here as many of our sample are still alive. However, the 
interquartile range for disease duration in the study population is adequate to represent a range 
of those with the condition. 
The proportion of patients in whom bulbar, respiratory or limb function is affected may differ 
slightly from other studies, as these figures look at the onset type as estimated at the time of 
diagnosis. Disease that has evolved to affect more than one domain may be described as mixed, 
and there is also the inclusion of a category for no disease pattern. A study by Chio et al claims 
that in most clinical and retrospective epidemiological studies bulbar onset is around 20-25%, 
limb is 75-80 and respiratory is <1%. It does, however, add the warning that respiratory onset 
may be under-represented as it may be more easily misdiagnosed.125 The mean scores for the 
ALSFRS-R domains in our population show that our patients are moderately disabled, with 
motor function being the most impaired domain. 
Marriage status could have a possible indirect link to QOL through the possibility of greater 
social support. An Irish study, by Clarke et al, found their rates to be: married 73.1%, single 
15.4%, widowed 7.7%, and separated 3.8%.38 A London based study found their rates to be: 
married 71.0%, single 12.9%, widowed 9.6% and divorced 6.5%.43 It should be noted that these 
rates and the significance attached to them will depend upon the local cultural and religious 
context. 
As discussed in chapter one it appears that patients’ focus moves away from occupation as a 
driver for QOL.16,28 Nonetheless a German study found that 91.9% of their MND population 
sample were unemployed (n=36), a rate similar to this sample population.64 
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Overall the above comparisons confirm that this study population is  an adequate one to 
investigate the desired psychosocial factors. Analysis of a large UK population will benefit overall 
understanding and contribute to the current literature. 
 
 
Factors 
For this thesis, the factors that will be evaluated in this population are as follows: 
 Depression 
 Anxiety 
 Social withdrawal 
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These factors have widely accepted, agreed definitions with well validated tools to measure 
them, including those used in the TONiC study. They are some of the most investigated factors 
in the systematic review, but the evidence is still inconclusive and requires further study.
 
Figure 2.3 Figure to show factors of interest in this thesis. 
All statistical analysis will be done in SPSS. 
Regression analysis will be used to investigate the significance of the proposed associations and 
will examine the relative importance of these variables for explaining variance in the outcome 
measure for each chapter. 
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The thesis will examine 5 multifactor models. The data set was modified such that participants 
who were missing data for any of the factors to be examined in a particular model were 
excluded from all analysis for that model. This ensures uniformity of the population between the 
initial single factor models, allowing direct comparison so that factors can be assessed by p value 
and F statistic to order the entry of these factors into the multifactor model. 
Total number of MND participants = 465 
 No missing data for depression, disability, duration and demographics = 286 
 No missing data for anxiety, hope or locus of control subscales = 224 
 No missing data for social withdrawal and QOL domains = 417 
 No missing data for social withdrawal and ALSFRS domains = 429 
 No missing data for Overall QOL, depression, anxiety and social withdrawal = 409  
Models that are significant at the p ≤ 0.05 level will be ranked by p value (smallest to largest) 
and then F statistic (largest to smallest). Factors will be added in this order using a ‘forwards’ 
method for building a regression model.  
Outliers will be determined by the residuals from the final model rather than the raw values. 
This is because all values from the scales are realistically possible, such that it would be 
disingenuous to remove data points as the data would no longer reflect TONiC’s real world MND 
cohort. Residuals of the final model will be assessed by Cook’s distance to determine whether a 
data point is having undue influence on the result of the model. These will be assessed 
graphically by the investigator and models will be tested again excluding data with high Cook’s 
distances. If no change in significance is found for any factors then the data is still included when 
reporting the final model. 
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Non-centred interaction terms will be tested between all the factors in the final, most 
parsimonious multifactor model. In the event of a significant interaction term, this will be 
reported in the final model and the interaction will be analysed graphically. This will be done by 
plotting one of the independent variables against the dependent variable, but whilst grouping 
the aforementioned independent variable by the second independent variable. This will produce 
multiple regression lines, which can then be compared. For example, if there were to be a 
significant interaction term for depression and anxiety when QOL is the outcome, then 
depression would be plotted against QOL with the data points for depression being grouped by 
anxiety level, either in even numbered groups or using specific cut-offs. 
When considering the multifactor models, it is worth considering how close they are to the 
original sample population (n=465) in terms of demographics. The table below shows values 
that were greater than 5% of the original value from the original value as orange and values 
greater than 10% from the original value in red. In the table below, it can be seen that the 
multifactor model with the greatest differences from the original sample population is the 
depression model; the most similar was the social withdrawal – ALSFRSR model. The table below 
shows that for most models there were moderate, and in the case of the depression model 
stark, differences when compared to the original sample population. These differences are 
unfortunate but cannot be avoided when using the chosen methodology of this study at the 
researcher’s skill level. Because of the differences demonstrated below, caution should be taken 
when interpreting the findings of this thesis. 
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Model 465 DEPRESSION ANXIETY SW-QOL 
SW-
ALSFRSR WHOQOL 
n 465 486 424 417 
427 - 
429? 409 
AGE 64.86 63.72 64.57 63.74 64.84 63.68 
DISEASE 
DURATION 26.17 28.58 31.4 27.23 26.82 27.35 
ALSFRS BULBAR 8.34 8.45 8.11 8.53 8.44 8.56 
ALSFRS RESP 9.81 9.67 9.84 9.81 9.82 9.8 
ALSFRS MOBILITY 13.48 13.62 13.24 13.6 13.54 13.59 
MALE % 60.6 63.6 61.9 63.1 60.8 62.9 
FEMALE % 39.4 36.4 38.1 36.9 39.2 37.1 
ONSET BULBAR 24.7 27.3 24.1 23.3 23.5 23.2 
ONSET LIMB 60 67.1 57.6 60.9 60.6 60.9 
ONSET UNKNOWN 15.3 5.6 18.3 15.8 15.9 15.9 
MS COHABITING 78.9 83.6 78.2 81.7 78.3 81.6 
MS SINGLE 5.1 4.5 5.5 4.6 5.3 4.7 
MS DIVORCED 7.3 5.6 6.8 7.1 7.4 7.2 
MS WIDOWED 8.8 6.3 9.5 6.6 9.1 6.5 
EMPL MED 
RETIRED 23.4 28.3 26.8 24.9 22.8 25.2 
EMPL RETIRED 54.6 49.3 54.5 51.6 54.5 51.1 
EMPL FULL TIME 9 10.1 6.7 9.6 9.6 9.5 
EMPL PART TIME 5.2 6.3 4.9 5.8 5.6 5.9 
EMPL OTHER 7.7 5.9 7.1 8.2 7.5 8.3 
HADSA 4.7 4.81 4.57 4.68 4.67 4.68 
HADSD 3.3 3.28 3.28 3.25 3.32 3.25 
Table 2.1 Table to show demographics and disease characteristics of the various multifactor 
models. Green = value within 5% of the original sample population. Orange = value greater than 
5% but less than 10% from the original sample population. Red = Value greater than 10% from 
the original sample population. 
It is also of interest to consider which factors contributed most to missing data in which models, 
which is shown in the tables below. For the depression model, it was shown that a substantial 
number of respondents did not have complete data for ‘disease duration’, domain 4 of the 
disability score, and domain 6 of the disability score. For the anxiety model, nearly half of 
respondents had missing data for the hope score. 
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Model Age 
Disease 
duration Gender Onset Type 
Marital 
status 
Employment 
status 
HADS-D 
modified 
Depression 0 64 3 0 11 0 15 
Table 2.2 Table to show, for the descriptives in the depression model, the number of missing 
entries. Green = Less than 5% missing data from the original sample population. Orange = 
Greater than 5% but less than 10% missing data from the original sample population. Red = 
Greater than 10% missing data from the original sample population. 
 
Model 
WHODAS 
D1 
WHODAS 
D2 
WHODAS 
D3 
WHODAS 
D4 
WHODAS 
D5 
WHODAS 
D6 
Depression 24 14 25 51 17 61 
Table 2.3 Table to show, for the disability domains in the depression model, the number of 
missing entries. Green = Less than 5% missing data from the original sample population. Orange 
= Greater than 5% but less than 10% missing data from the original sample population. Red = 
Greater than 10% missing data from the original sample population. 
Model 
HADS-A 
modified 
Herth Hope 
Index 
Internal 
LOC  Chance LOC Others LOC 
Anxiety 15 214 25 27 24 
Table 2.4 Table to show, for each factor in the anxiety model, the number of missing entries. 
Green = Less than 5% missing data from the original sample population. Orange = Greater than 
5% but less than 10% missing data from the original sample population. Red = Greater than 10% 
missing data from the original sample population. 
Model 
Social 
withdrawal Physical health 
Psychological 
health 
Social 
relationships 
Environment 
and financial 
resources 
SW - QOL 0 8 8 48 8 
Table 2.5 Table to show, for each factor in the SW-QOL model, the number of missing entries. 
Green = Less than 5% missing data from the original sample population. Orange = Greater than 
5% but less than 10% missing data from the original sample population. Red = Greater than 10% 
missing data from the original sample population. 
Model 
Social 
withdrawal ALFRS-R Bulbar 
ALSFRS-R 
Respiratory 
ALSFRS-R 
Motor 
SW - 
ALSFRSR 0 12 21 20 
Table 2.6 Table to show, for each factor in the SW-ALSFRS model, the number of missing entries. 
Green = Less than 5% missing data from the original sample population. Orange = Greater than 
5% but less than 10% missing data from the original sample population. Red = Greater than 10% 
missing data from the original sample population. 
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Model 
Total 
QOL 
HADS-D 
modified 
HADS-A 
modified 
Social 
withdrawal 
GQOL 48 15 15 0 
Table 2.7 Table to show, for each factor in the GQOL model, the number of missing entries. 
Green = Less than 5% missing data from the original sample population. Orange = Greater than 
5% but less than 10% missing data from the original sample population. Red = Greater than 10% 
missing data from the original sample population. 
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Investigating Depression in Motor 
Neuron Disease 
Introduction 
Factors 
The systematic review highlighted that depression is the factor which has been most 
investigated with respect to QOL in MND. This is possibly because of the healthcare 
practitioner’s familiarity with the concept, given it is a psychiatric diagnosis (ICD 10/DSM-V), and 
thus there is information regarding aetiology, diagnosis, treatment (National Institute for Health 
and Clinical Excellence (2009) Depression in adults: recognition and management. NICE 
guideline (CG90))126  and prognosis with available well validated screening measures.  
It is also likely to be due to the recognised relationship between long-term physical health 
conditions and depression127, as well as the general attitude that a diagnosis of MND is 
devastating, and would increase susceptibility to depression. 
Previous studies have demonstrated a relationship between depression and some 
demographic/disease factors such as gender, employment status, ALS type and educational 
status, but these studies did not use a UK cohort.48,85 The effect of these factors may differ 
between cultures, as different emphasis may be placed on them, and thus the relationship 
between depression and some demographic factors will be studied in the large UK TONiC 
cohort.  
One factor with conflicting evidence about its relationship to depression is time, specifically 
whether depression worsens with time. As described in the systematic review, the study by 
Jones et al found that depression increased over time, and they posited physical decline as a 
contributing factor.76 However, several studies have shown that depression is stable over 
time.58,77,78 It is possible that a relationship between time from diagnosis and depression could 
be confounded by a number of factors, including physical decline as suggested previously, and it 
would be valuable to re-examine this relationship. 
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Physical function has been linked to depression before45,46,85 but it would be useful to examine 
how these factors may be linked, by examining whether patients ability to undertake certain 
activities is associated with depression, thus contextualising their physical function in terms of 
disability. 
Measuring depression 
An issue raised in the systematic review is how depression is measured in studies. In the MND 
population, screening tools are often used both clinically and in research to evaluate levels of 
depression. Screening tools are not diagnostic and so conclusions reached in research may not 
be in relation to categories of ‘diagnosed depression’ vs. ‘no depression’ per se, but in relation 
to categories of ‘no depression’, ‘possible depression’ and ‘probable depression’ (labels given 
depending on cut-off scores defined within the measures). 
The Hospital Anxiety and Depression Scale (HADS) is a 14-item screening tool for both anxiety 
and depression and can be split into two subscales accordingly – the HADS-A and the HADS-D. 
The HADS-D has 7 items with cut-offs of scores ≥11 for ‘probable depression’, 8-10 for ‘possible 
depression’ and ≤7 for ‘no depression’. In the general and other disease populations, the HADS 
has been shown to have good sensitivity and specificity when compared with the Structured 
Clinical Interview for DSM disorders (SCID-1 DSM-IV version) for identifying psychiatric 
disorder.128 A study on breast cancer patients found that the depression subscore had good 
sensitivity and specificity when compared to a DSM diagnosis of major depression, but a positive 
predictive value (PPV) of 36%.129 The low PPV means that the HADS-D is likely to overestimate 
the prevalence of depression in this population. 
The results of a recent study using Rasch psychometric validation concluded that the HADS-D 
could be modified for use in the MND population by removing item D8 “I feel slowed down”, 
and revising the cut-off scores to ≥8 for ‘probable depression’, 5-7 for ‘possible depression’ and 
≤4 for ‘no depression’.119 This adjustment had previously been made by some authors, as it was 
thought reasonable to assume that item D8 may be confounded by the physical impairment that 
comes with MND.43,130 However, there was not the evidence to support the modified measure at 
that time. 
68 
 
A benefit of screening scales is that they generate ordinal data which, given appropriate 
conditions, can allow use of inferential statistical techniques looking at ‘relationships and 
correlations’, as opposed to categorical data which only allows statistical techniques looking at 
‘differences between groups’. The Rasch analysis of the HADS resulted in a modified scale that 
produces interval level data allowing the use of more simple, conventional, and robust 
inferential statistical techniques. 
Another benefit of screening tools is that the diagnostic interview is particularly resource 
intensive to administer and interpret when compared to screening tools, which are often 
patient-reported. This is advantageous as large volumes of data can be collected in a shorter 
space of time. Thus, the diagnostic interview is the gold-standard for identifying depression but, 
for the reasons above, psychometrically validated screening tools could be regarded as an 
acceptable proxy for investigating depression in large cohorts.131–138 
Method 
Aim: To investigate some factors’ association with depression in this TONiC MND cohort. 
Research questions: 
1. Are certain demographic factors significantly associated with depression in MND? 
2. What is the relationship of time from diagnosis and disability to depression in MND and 
do these factors interact? 
Analysis 
This study used a regression model, depression being the dependent variable with the factors 
age, gender, onset type, marital status, employment status, time from diagnosis and disability as 
the independent variables. Multiple regression analysis allows each factor to be checked on its 
own for significance, but then also together to examine for confounding. 
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The use of disability over a measure of pure physical function was intended to allow an 
examination of specific areas affected by physical decline such as the domains of self-care, 
mobility and communication. Additionally, there are no interventions available currently to 
improve a patient’s physical function but there is the possibility of intervention aimed at 
improving a patient’s disability, making the study more clinically relevant. Finally, the measure 
of disability is patient-reported as well as contextualised in terms of activities and patient’s 
ability to participate in them; thus, it has the benefit of being a subjective measure of the 
patient’s ‘lived experience’ of MND.  
Initial plots did not suggest any non-linear relationships between the factors and depression, so 
multiple linear regression was chosen as an appropriate method. 
Participants 
 The data set was modified such that participants who were missing data for any of the factors 
to be examined were excluded from all analysis. This ensured uniformity of the population 
between the initial single factor models. 
Total participants: n = 465 
Participants with complete data for depression, disability, time from diagnosis and 
demographic: n = 286 
Scales 
o Depression was measured using the HADS-D subscale modified for use in MND as per 
the paper by Gibbons et al.119 
 
o Disability was measured using the WHODAS 2.0, which is a disability scale by the World 
Health Organisation examining 6 domains, although domain 5 is split into 2 
subdomains.139 
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Domain Measures 
Domain 1 Understanding and Communicating 
Domain 2 Getting around 
Domain 3 Self-care 
Domain 4 Getting along with people 
Domain 5a Life activities – household questions 
Domain 5b Life activities – work and school 
Domain 6 Participation in society 
 Table 3.1 Table to show the domains examined by the WHODAS 2.0 
Models 
Overall model 
To generate an overall multifactor model, single factor models were run for the following 
factors: 
 WHODAS 2.0 domains – domain scores were modified using the item-response-theory 
based scoring from the WHODAS 2.0 handbook.139 Domain 5b, the ‘work and school’ 
subsection of life-activities, was not included for regression, as it was only rarely 
completed due to the nature of MND. 
 Time from diagnosis – measured in ‘months from diagnosis’. 
 Age  
 Gender – Scored as ‘male’ or ‘female’. 
 Onset type – Scored as ‘limb’, ‘bulbar’ and ‘unknown’. ‘Unknown’ was chosen to be the 
comparison variable and ‘limb’ and ‘bulbar’ as the dummy variables. 
 Marital status – Scored as ‘single’, ‘cohabiting/married’, ‘divorced’, ‘widowed’. 
‘Cohabiting/married’ was chosen to be the comparison variable and ‘single’, ‘divorced’ 
and ‘widowed’ were coded as the dummy variables. 
 Employment status – Scored as ‘working full-time’, ‘working part-time’, ‘medically 
retired’, ‘retired’ (other than medical), and ‘other’. ‘Medically retired’ was chosen as the 
comparison variable and ‘working full-time’, ‘working part-time’, ‘retired’ and ‘other’ 
were coded as dummy variables. 
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Interaction model 
To specifically test the interaction between time and disability, a summed score for the disability 
domains was calculated and multiplied by ‘time from diagnosis’ to generate the interaction 
term. Then a multifactor model was tested with the factors ‘disability’, ‘time from diagnosis’ and 
the ‘interaction term’ being added in that order. 
Results 
Overall model 
Single factor models that were statistically significant: 
 WHODAS 2.0 domain 1 (Understanding and Communicating) (F1,284 = 74.046, p < .001) 
 WHODAS 2.0 domain 2 (Getting around) (F1,284 = 47.090, p < .001) 
 WHODAS 2.0 domain 3 (Self-care) (F1,284 = 69.755, p < .001) 
 WHODAS 2.0 domain 4 (Getting along with people) (F1,284 = 85.965, p < .001) 
 WHODAS 2.0 domain 5a (Life activities – household questions) (F1,284 = 72.977, p < .001) 
 WHODAS 2.0 domain 6 (Participation in society) (F1,284 = 128.220, p < .001) 
Single factor models that were not statistically significant: 
 Time from diagnosis (F1,284 = 0.460, p = .498), Logn time from diagnosis (F1,284 = 1.486, p = 
.224),  
 Age (F1,284 = 0.138, p = .711) 
 Gender (F1,284 = 0.000, p = .997)  
 Onset type (F2,283 = 0.230, p = .795)  
 Marital status (F3,282 = 1.365, p = .254) 
 Employment status (F4,281 = 1.050, p = .382)  
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Significant single factor models Non-significant single factor models 
Domain 1 (Understanding and 
Communicating) 
Time from diagnosis 
Domain 2 (Getting around) Age 
Domain 3 (Self-care) Gender 
Domain 4 (Getting along with people) Onset type 
Domain 5a (Life activities – household 
questions) 
Marital status 
Domain 6 (Participation in society) Employment status 
Table 3.2 Table to show significant and non-significant single factor models. 
In order to find the most parsimonious model a ‘forwards’ approach was used which resulted in 
a model incorporating domains 6, 4, and 1 (F3,282 = 58.071, p < .001). Interaction terms for these 
factors were not significant. The final model accounted for 38.2% of the variance in HADSD 
scores as shown by an R2 of 0.382. 
 The final model’s regression equation was as follows: 
 
Discussion 
Demographics 
All demographic factors examined in this study were found to be non-significant in terms of 
association with depression. This is consistent with a previous paper by Tedman, Young, and 
Williams140, but is contradicted by Cui et al.141 
 
HADSD = 0.370 + 0.037*domain 6 + 0.017*domain 4 + 0.028*domain 1 
 
Interaction model 
In the model testing for an interaction between disability and time from diagnosis, the ‘total disability’ 
score was significant as a single factor model (F1,284 = 127.646, p < .001). The addition of ‘time from 
diagnosis’ did not produce a significant R square change (p = .119) and the addition of the interaction term 
also did not produce a significant R square change (p = .229). 
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Relationship of depression with time from diagnosis of MND 
This study does not support a significant relationship between depression and time from 
diagnosis of MND. Nor did it support a significant interaction between time and disability when 
examining depression. However, whether depression increases over time and as death 
approaches may be due to a myriad of other confounding factors such as religiosity/spirituality 
and social support. Other factors important to consider are adjustment and coping; future 
research could divide sample populations into high and low adjustment or divide them by 
coping style. Another important factor to consider would be whether patients are receiving 
effective palliative care, and whether they are satisfied with this care. 
Another consideration is whether the magnitude of impact of various psychosocial factors may 
change over time. For example, a thematic study by Hecht et al found that social isolation was 
named as being one of the most important psychosocial factors at T2 whereas it was not at T1.44 
Similarly, the paper by Bremer et al found that, in their sample, private religiosity was not 
initially related to QOL.37 However, it showed a trend to increase with time and by 1 year the 
combined effects of private and public religiosity accounted for 53% of the variance in QOL. 
They suggested that public religiosity may provide additional support through social relations, 
but the above examples still demonstrate the possibility of change in psychosocial factors’ 
importance over time. Matuz et al commented on how the degenerative course of MND 
exposes individuals to short and long-term stressors.49 They suggested that patients utilise 
different coping styles, depending on (i) the stage of the disease and (ii) which type of stressor 
they are attempting to cope with at that time. Following this, they suggested that despite the 
idea that ‘confrontation is good and avoidance is bad’, denial or avoidant coping may be helpful 
in terms of maintaining QOL until later in the disease course, when it becomes maladaptive. 
A beneficial factor increasing its effect over time, such as improved coping, may go some way to 
explaining why, despite decline in other areas such as functional ability, depression is not 
correlated with time in this cohort. 
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Disability 
Significant single factor models confirm the importance of considering domains one 
(understanding and communicating), two (getting around), three (self-care), four (getting along 
with people), five A (life activities – household tasks) and six (Participation in society) of the 
WHODAS 2.0 questionnaire when considering a patient’s mental health. 
The most parsimonious model included domains 6, 4 and 1. The coefficients of these scores may 
seem small but the domain scores could be in the hundreds and so the magnitude of these 
factors should not be underestimated, as demonstrated by the variance in depression explained 
by the final model. The final model demonstrates the importance of social disability for patients 
with MND. Due to the cross-sectional nature of this analysis the direction of effect cannot be 
determined, and so it may be that social disability is a driver for increased levels of depression – 
or it could be that higher levels of depression cause patients to struggle to communicate, get 
along with people and participate in society. Equally, it is just as likely that the interaction is bi-
directional. 
The results of this study are consistent with previous studies, which have explored the 
relationship between depression and functional ability in MND.142,143 Hogg, Goldstein and Leigh 
used the Barthel Index, which looks at independence of mobility and speech, and found 
significant correlation with depression.143 Emotion, sleep and eating scores of the sickness 
impact profile (SIP) were also correlated with depression, showing further links with the 
disability incurred by physical limitation. They additionally found a significant association 
between depression and social interaction, further supporting the findings of this study’s final 
model. In Matuz et al’s study, they found that the factor in their model that best predicted 
severity of depressive symptoms was perceived social support, which lends support to the social 
factors aspect of this study’s findings.49 
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Physical function 
Physical function’s relationship with QOL could be considered confusing; physical impairment 
has been shown to be a risk factor for depression45,46,85, but, in spite of this this, lower physical 
function does not appear to be associated with lower QOL17,18,20,43. Considering the strong link 
between depression and QOL, this is a curious finding and perhaps future studies could seek a 
mitigating factor. It may be that initially physical function is associated with adjustment, but as a 
response shift occurs, this link weakens, and there is no impact on QOL. 
To reiterate, disability was chosen instead of physical function in this chapter, as it allows 
physical decline to be contextualised in terms of ability to undertake or participate in activities 
such as self-care, getting around and communicating with others. Additionally, whilst physical 
function cannot currently be improved in MND with any of the available pharmaceutical 
armament, interventions can be aimed at reducing disability. This notwithstanding, it is worth 
considering that lower physical function may be a separate risk factor for depression, outside of 
the disability it entails.  
It could also be that a patient’s limited physical function serves as a reminder of the progressive 
and ultimately fatal nature of the disease course. A similar sentiment was suggested by Hogg, 
Goldstein and Leigh143. Narrative interviews have reported patient’s comments that “the 
diagnosis is a 'death sentence'” and that “life is already over.”30 
It would be interesting to explore whether all the variance in depression scores explained by 
physical function is absorbed by disability, or whether physical function has a significant unique 
contribution. 
It is shown in this study that the disability that results from physical limitation impacts strongly 
on the patient’s mood, and this supports prioritising interventions towards adaptations, devices 
and services that can reduce the impact of physical limitation on disability. For example, in 
interviews about the impact of neck weakness, some of the problems described included the 
social limitations of low eye-level and the lack of freedom as it was more difficult to get 
around.144 This was then supported in various ways by physiotherapists and occupational 
therapists for example with the use of splints and neck supports. This does not of course 
improve a patients’ neck strength, but does reduce their disability. 
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Depression has been shown in several chronic diseases, including multiple sclerosis145 and 
COPD146 to worsen functional status, or at least perceived disability. Thus, the relationship may 
be found to be bi- directional. 
Perceived health status 
Although not examined in this study, it is interesting to consider how impaired physical function 
or disability may impact on perceived health status. Perceived health status was found to 
predict depression in South Korean ALS patients85, and this demonstrates the importance not 
only of objective impairment but also of the subjective experience of the patient. 
There are a number of interventions which may improve or worsen perceived health status, 
including those aimed at reducing disability, as well as physical treatments such as P.E.G. or 
ventilator support. In addition, there may be additional therapeutic potential for improving 
perceived health status in the form of psychological intervention. It has been shown in many 
disease groups and in the healthy population that organised programs aimed to improve rates 
of physical activity and/or nutrition can have significant benefit on self-perceived health status. 
This includes, but is not limited to, sprint training, yoga, tai-chi, empowerment focussing on 
physical activity, individualized feedback-based virtual reality (IFVR) exercise, support groups 
and CBT focussed on exercise and diet, and group exercise coupled with nutrition classes.147–153 
These examples are of course confounded by the evidence about the benefits of exercise on 
mental health154,155 aside from self-perceived health status and additionally some will be less 
applicable to MND patients due to their physical limitations. 
Benefits to perceived health status from psychoeducational approaches that do not involve 
physical activity have been seen in different disease groups. Some examples are as follows: 
structured self-care telephone talks156, short-term CBT intervention via telephone157, 
Psychoeducational Intervention Program158, therapeutic skill building and support activities 
including reinforcement with practice and role-playing to reduce stress and burden associated 
with caregiving159, counselling sessions led by psychotherapists160, motivational interview-based 
health coaching161, acceptance training intervention combined Rational Emotive Behaviour 
Therapy with music, relaxation, and guided imagery162. These types of interventions may have a 
wider merit in terms of their effect on other psychosocial factors e.g. self-esteem, self-efficacy, 
or depression. 
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The use of telephone based interventions may be seen as beneficial in terms of resource cost as 
well as having additional benefit for MND patients with reduced mobility, improving their access 
to psychological therapies. 
Acceptance training intervention may have particular relevance to MND. Meaning or 
transcendence based coping is related to the idea of response shift, and is defined by some as 
acceptance of self and others and altruism163. There is evidence in a wide range of illnesses that 
the life-changing impact of an intractable disease can cause an increase in self-transcendence, 
with an acknowledgment that this can have a wide range of benefits in terms of mental well-
being.164 Some may argue that coping with the existential and psychosocial crises that the 
diagnosis of a fatal illness brings, accelerates a person’s journey through the psychosocial stages 
as suggested by Erikson165. If these psychosocial crises are resolved, then the patient may adjust 
to their terminal diagnosis more readily than expected. 
Meaning focused coping is discussed in further detail in the following chapter in relation to both 
hope and locus of control. 
Prevalence of depression 
Prevalence of ‘probable’ depression as per the modified cut-off points given by Gibbons et al119 
=7.1% (n=450), and ‘possible’ depression =22.3%. 
Treatment for depression in MND 
A 2014 review, “The evidence for symptomatic treatments in amyotrophic lateral sclerosis” 
concluded that although usual antidepressants and cognitive behavioural therapy (CBT) 
approaches are used, no randomised controlled trials have studied the treatment of depression 
in MND.166 This was reiterated in a 2016 review which recommended multidisciplinary 
management, psychological support, palliative care, physical therapy as well as the standard 
drug treatments used in other conditions for the management of psychological symptoms 
including depression in MND patients.167  This is consistent with recommendations in the 2009 
NICE guidance for “Depression in adults with a chronic physical health problem”.127 
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A paper quoting expert opinion states that there is a broad consensus that selective serotonin 
reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) are helpful.74 The authors add 
that TCAs treat symptoms of pseudohypersalivation and insomnia due to their anticholinergic 
effects, which may be an added benefit.  
A paper investigating the impact of long-term medical conditions on the outcomes of 
psychological therapy by Delgadillo et al concluded that standard stepped-care interventions (in 
the form of CBT) are “insufficient to support patients with multiple morbidity.”168 In this study, 
they investigated the treatment of individuals who were depressed with no long-term condition 
and compared this with the same treatment in patients with multiple morbidity. They found 
that using the same intervention style for chronically ill patients who were depressed was not as 
effective, when compared to depressed patients with no long-term condition. They also noted 
that in most self-reported long-term conditions, patients were significantly more likely to 
receive more intensive and costly psychological interventions, but that in some groups higher-
intensity therapy was associated with higher average post-treatment distress, compared to low-
intensity therapy. They suggested that high-intensity therapy was not necessarily superior to 
low-intensity therapy in a primary care setting for patients with long-term conditions. 
One interpretation of this study is that a particular, evidence based, CBT intervention for 
psychological symptoms including depression may not be as effective in MND patients. Patients 
with MND may require different therapeutic interventions for the treatment of any 
psychological symptoms. 
Following on from this, a study examining both MND patients and late-stage cancer patients 
found similar rates of depression as per the Beck depression inventory, but found that the 
characteristics or ‘quality’ of the depression differed between the groups.169 MND patients 
had higher scores for demoralisation and hopelessness, as well as suicidal ideation. Cancer 
patients suffered more with anhedonia. If further research corroborates these findings, this 
could inform both assessment and management approaches in different patient groups. 
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Future research 
Depression and time 
A relationship between depression and time would need to take multiple psychosocial factors 
into account. One idea might be to examine whether there is an association early in the disease 
course, when patients may not have compensating psychosocial mechanisms. 
Disability and social programs 
Further research could investigate whether interventions based around disability have a positive 
impact on individual’s mental health or – by extension – QOL. Yet, care should be taken not to 
simply try to improve these factors via external support without improving how patients feel 
about these factors. Investing more in support services to help with ‘self-care’ (washing, eating, 
dressing) or household activities may not improve patients’ outlook in the intended way, as it 
may be the fact that they cannot accomplish these things for themselves that distresses them – 
any success of the aforementioned services may also have to do with social factors, more so 
than the impact the service has on their disability or burden.  
Social programs including support groups could be beneficial not only in terms of social factors, 
such as improving support and reducing withdrawal and isolation, but also in terms of WHODAS 
domains six and four (‘participation in society’ and ‘getting along with people’ respectively). 
However, these programmes may be problematic as people are often reluctant to join initially – 
for a plethora of reasons, from denial to embarrassment, or to inconvenience – and often only 
see the benefits after joining. This is coupled with themes from qualitative work, as mentioned 
in chapter one, indicating that MND patients may switch their focus to consolidating existing 
relationships as opposed to seeking new friendships.28 
Some studies have suggested that patients can be distressed by the content of discussions, the 
purpose of such groups and by seeing peers who are more advanced in their illness. Some would 
rather engage in activities unrelated to MND.170 
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Locock and Brown examined support groups, social comparison and two key themes of ‘valuing 
camaraderie and comparison’ and ‘choosing isolation’.171 They noted that groups offered 
practical and social support and, with respect to the first key theme, an opportunity for social 
comparison, where seeing others coping well could provide hope, and seeing others worse off 
could make people feel better about their own situation. This notwithstanding, they also noted 
that most people were also shocked and saddened by seeing other individuals with the same 
condition, and that the second key theme, choosing isolation, can be a deliberate defence 
mechanism to avoid seeing how much worse they could be in future. Choosing isolation could 
also be used when attending the group caused disruption to a person’s identity such that they 
felt defined as ‘a person with MND’ rather than ‘the person I am that happens to have MND’. 
Balancing benefits and psychological distress, as well as an individual’s ‘changing needs and 
fears’, may result in changing levels of involvement over time.  
When examining resilience in neurological disease, McCabe et al found that those with high 
levels of adjustment engaged more in sport, groups, clubs and classes than individuals with low 
adjustment.172 It was seen that those with a high level of adjustment intended to use activities 
to maintain a positive outlook, not focus on the illness more than necessary and remain 
physically active. However, they did also find that those in the low-adjustment group did report 
support groups as helping them cope with their illness. A resource effective way of investigating 
the impact of support groups would be to research the benefits and costs (emotional and 
monetary) of existing support groups using both qualitative and quantitative methods. 
Psychological Interventions to improve psychological wellbeing including depression in MND 
There have been previous calls in the literature for research into psychological support for MND 
and for recommendations and ‘best practice’ guidelines to be developed. There is the additional 
suggestion that interventions for other life-threatening disorders could be modified to suit MND 
patients.173 
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In a 2006 review, a revised model of adjustment for chronic disease, incorporating many 
psychosocial models, was proposed, and the authors felt that this could be used to guide the 
improvement of treatment.174 They argued that most interventions for psychopathology focused 
on cognitive strategies to challenge unhelpful beliefs about their illness, but did not target other 
processes such as response shift, meaning-finding and other relevant factors. Consequently, it 
was argued that the most appropriate strategies for an individual may be underutilised, and that 
their model could act as a guide to identify, at a particular time point, which strategy would 
most facilitate adjustment. 
Processes which they recommended considering include: 
 Schema-enmeshment 
 Self-regulation model 
 Reality-matching 
 Response shift 
 Abstraction of meaning 
 Benefit finding 
Research such as this could be adapted to examine new methods of psychological support for 
MND patients. 
The review also commented on the tendency of depressed individuals to selectively attend to 
and recall negative information and disability related words. Thus, in the psychological support 
of individuals with MND the cognitive biases of those with depression should be accounted for. 
This is relevant for both the direct provider of psycho-supportive therapies (CBT, psychodynamic 
therapy etc) and the entire healthcare team. Health-messages can be tailored to avoid negative 
illness words so that recall of the overall message is not affected. 
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Psychological distress and mortality 
Some studies have shown psychological distress to be associated with earlier death.175,176  
However, a review by Chio et al comments that psychological distress could have been the 
consequence of more rapidly progressive disease177, although McDonald et al claimed to control 
for length of illness, disease severity and age175. Chio et al also warned that MND patients with 
florid FTD are known to have shorter survival time, and so psychological disorder could have 
been due to cognitive impairment, but this could not be distinguished in the studies, as they did 
not include ‘rigorous’ frontal lobe assessment.177 
If psychological distress is associated with earlier mortality in MND patients, then there is 
additional benefit to be gained from studies which explore psychological symptoms in MND 
aside from understanding the impact on QOL. 
Limitations of this study 
Limitations include the reduction in cohort size due to elimination of participants with missing 
data for any of the factors investigated. The validity of this model’s findings relating to some of 
the demographic factors may rightly be questioned due to both the potential biases in the 
overall TONiC cohort, as well as the findings that the reduced cohort in this model had moderate 
differences from the original cohort, particularly with respect to marital status, employment 
status and onset type. Of the other factors examined, disease duration, WHODAS domain 4, and 
WHODAS domain 6 had greater than 10% missing data so there may be issues with these 
measures that could have affected the results of this model. 
This model is by no means comprehensive and there may be many other factors whose 
relationships with depression are unappreciated in this model and which may have changed the 
significance of those factors examined here. 
An issue arose with the forward building of the multiple linear regression model, as the results 
given in SPSS meant that the order of p values for the WHODAS 2.0 domains could not be 
determined. The p value was reported to 3 decimal places and as such was reported to equal 
less than .001 for all the domains. This meant that the order of entry was determined by F 
statistic. 
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Conclusion 
In conclusion, this study has shown a significant association between disability and depression in 
MND with particular emphasis on ‘participation in society’, ‘getting along with people’ and 
‘understanding and communicating’. There may be merit in examining physical function 
separately to disability for any number of distinguishing reasons mentioned in the discussion. 
Demographic factors, and ‘time from diagnosis’ were found to be non-significant with respect to 
any association with depression, but there may be confounding factors to consider. With 
regards to ‘time from diagnosis’, an interaction with disability was considered but this was non-
significant. The management of depression in MND patients is in accordance with general 
guidance for treating depression, but as specific research pertinent to MND becomes available 
this may be improved. Further research should investigate the temporal effects of various 
psychosocial factors.  
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Investigating Anxiety in Motor Neuron 
Disease 
Introduction 
The systematic review highlighted that anxiety has been the second most investigated factor 
with respect to QOL in MND. As with depression this is likely to be due to healthcare 
practitioners’ familiarity with the concept as a psychiatric diagnosis, compared to some other 
less well defined psychosocial constructs, and the availability of validated measures for anxiety. 
Considering this, it is of interest to investigate the significance of some other factors and their 
relationship to anxiety.  
Hope 
Psychosocial factors such as hope are now more readily discussed by traditional medical 
specialities who care for people with chronic health conditions, both due to the increase in joint 
care with palliative services, as well as increased adoption of the biopsychosocial model of 
healthcare. The systematic review identified two papers which investigated hopelessness in 
relation to QOL in MND. A PubMed search (22/03/17) using the key words ("hope" OR 
"hopelessness" AND "Motor neuron disease") identified 50 studies. A lot of these studies were 
talking about hope in relation to a new intervention, but there were a number of studies which 
examined the role of hope in MND. 
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Hopelessness is classically associated with depression in the general psychiatric literature, but 
may be linked to other factors such as anxiety also. A PubMed search (22/03/17) using key 
words (“anxiety” AND “hope”) identified 986 studies commenting on both of these factors in 
various illness groups. Narrowing this search to neurological illness (using the key words 
"neurology" OR "Neurological" AND "anxiety” AND “hope") identified 28 studies and narrowing 
the search to MND (using the key words "motor neuron disease" OR "MND" AND "anxiety” AND 
“hope") identified 7 studies. Of these seven studies, three focussed on dignity therapy, one was 
a review, one was investigating non-invasive ventilation, one investigated caregivers and 
another was looking at Tourette’s syndrome. From this it can be said that it would add valuable 
data to the literature to examine the relationship between hope and anxiety in the TONiC MND 
cohort. 
It may seem paradoxical that people could have hope in a disease such as MND. The limited 
treatment options and unrelenting progression could be considered a barrier to hope. 
Progressive weakness and symptom burden strips patients of their independence and leaves no 
prospect of true improvement of physical function. There is an increased awareness of MND 
research, particularly after the recent ‘ice bucket challenge’178–180 but the results of disease 
modifying drug studies are thus far disappointing, so that, depending on an individual’s 
optimism, this may not engender much hope.  
However, this is a limited view of hope. A study examining “generalised hopes” in stroke 
patients by Soundy et al found three key “themes” of: social identity, meaningful activities and 
experiences, and relief from suffering.181 Fanos et al identified numerous hope “categories” 
used by MND patients including: ‘hope for a cure’, ‘social support’, ‘search for information’, 
‘spiritual beliefs’, ‘limiting the impact’, ‘adapting to changing capacities’, ‘living in the moment’, 
and ‘self-transcendence’.182 Understanding that hope is multifaceted demonstrates its potential 
importance as an area of study, and for consideration in clinical practice. 
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One study acknowledges that hope in MND patients may be experienced differently from other 
patient groups due to their certain knowledge of the disease’s fatality from the point of 
diagnosis. In this paper meaning is mentioned again and hope is also considered to include “a 
peaceful acceptance of life, and its inexplicable beginnings and endings”.183 This links back to 
another paper by Soundy et al, who suggested hope can be expressed as either a paradox, a 
dichotomy or as transcendence.184 The latter term would fit with other findings in MND with 
regards to meaning finding, positive reappraisal and response shift. Having no meaning in life 
has been found to predict hopelessness in MND, and this may be one of the ways in which 
meaning in life is associated with adjustment and associated outcomes such as mood.185 
Locus of control 
Locus of control (LOC) is a way of describing to what extent individuals attribute situations in 
their life to be controlled by themselves or controlled by something other than themselves.186 If 
an individual believes that circumstances are under their control then this is described as an 
internal locus of control, whereas, if they believe that circumstances are out of their control, this 
is described as an external locus of control. External locus of control can be broken into the 
belief that powerful others (e.g. doctors, teachers) control the individual’s situation or that 
chance decides their fate; from this we get the two subscales of external locus of control: 
‘powerful others’ and ‘chance’. Individuals can have varying measures of each subscale of locus 
of control without necessarily identifying with one type of LOC entirely. 
Due to MND’s relentless disabling progression and lack of cure, it would be interesting to see 
how ratings of internal and external locus of control affect the level of anxiety experienced by 
patients. There is a large amount of literature examining the relationship between anxiety and 
locus of control187–189, but very few papers look at locus of control or perceived control in MND 
specifically190–193, and none appear to examine the relationship with anxiety.  
The reality-matching hypothesis (AKA goodness-of-fit hypothesis) is a hypothesis relating to 
locus of control, which suggests that the best adjustment occurs when an individual’s appraisal 
of a situation or disease’s controllability matches closely with that situation or disease’s actual 
controllability.194 So if a situation is controllable by the individual then an internal locus of 
control will benefit them more than an external locus of control and for an uncontrollable 
situation an external locus of control will benefit them more than an internal locus of control. 
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Therefore, one could hypothesise that due to MND’s uncontrollability a highly rated internal 
locus of control may be associated with negative outcomes such as mood. However, Matuz et al 
found the appraisal of emotion and problem-focused coping potential significantly predicted 
level of depression in MND patients and suggested from this that higher internal locus of control 
was associated with lower levels of depression.49 
Method 
Aim: To investigate some factors’ association with anxiety in this TONiC MND cohort. 
Research questions: 
1. Are lower levels of hope associated with anxiety in MND. 
2. Is a more internal or external locus of control associated with more anxiety in MND. 
Analysis 
Initial plots did not suggest any non-linear relationships between the factors and anxiety, so 
multiple linear regression was chosen as an appropriate method.  
Participants 
The data set was modified such that participants who were missing data for any of the factors to 
be examined were excluded from all analysis. This ensured uniformity of the population 
between the initial single factor models. 
Total participants: n = 465 
No missing data for anxiety, hope or locus of control subscales: n = 224 
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Scales 
o Anxiety was measured using the HADS-A subscale modified for use in MND as per the 
paper by Gibbons et al.119 The results of Rasch psychometric validation concluded that 
the HADS-A could be modified for use in the MND population by removing item A11 “I 
feel restless as if I have to be on the move”, combining A3 and A5 as a testlet and 
changing the cut-off points. The cut-offs were changed from ≥11 for ‘probable anxiety’, 
8-10 for ‘possible anxiety’ and ≤7 for ‘no anxiety’ to ≥9 for ‘probable anxiety’, 7-8 for 
‘possible anxiety’ and ≤6 for ‘no anxiety’. The reliability of the modified scale was stated 
as suitable for both clinical work and research. 
 
o Hope was measured using the Herth Hope Index (HHI), which is a 12-item, abbreviated 
version of the Herth Hope Scale.195 It is a multidimensional measure with three 
subscales: temporality and future, positive readiness and expectancy, and 
interconnectedness. 
 
o Locus of control was measured using Form C of the Multidimensional Health Locus of 
Control (MHLC) scale. This 18-item scale is for measuring LOC in chronic health 
conditions and can be divided into its three subscales ‘internal’, ‘chance’ and ‘powerful 
others’.196 
Models 
Single factor models were run for the following factors: 
 Hope 
 Internal locus of control 
 Chance locus of control 
 Powerful others locus of control 
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Results 
Of the single factor models ‘hope’ was found to be significant (R2 = .235, F1,222 = 68.163, p < .001) 
but none of the MHLC scales (internal, chance, others) were: 
 Internal  (F1,222 = 2.390, p = .123) 
 Chance  (F1,222 = 3.022, p = .084) 
 Others   (F1,222 = 0.151, p = .698) 
Significant single factor models Non-significant single factor models 
Hope Internal locus of control 
 Chance locus of control 
 Powerful others locus of control 
Table 4.1 Table to show significant and non-significant single factor models. 
The final model with hope explained 23.5% of variance in HADS-A scores. 
The final model’s regression equation was as follows: 
 
Discussion 
Findings 
Hope was found to be a significant single factor model, demonstrating its importance with 
respect to anxiety and supporting its wider relevance as a psychosocial factor. Hope alone 
explained 23.5% of the variance in anxiety scores. 
None of the locus of control subscales were found to have a statistically significant association 
with anxiety and possible reasons for this are discussed below. 
 
 
 
Anxiety (HADSA modified) = 12.893 – 0.326*HHI 
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Hope 
The role of hope is often discussed in relation to depression, and has been associated with 
suicidal ideation197 and desire for assisted death in MND34,198. Averill et al suggested that 
hopelessness and end-of-life concerns are more common than clinically significant depression in 
MND patients, and emphasise the importance of assessing a wider range of psychosocial factors, 
other than just depression.199 
One might suppose that hope would decrease as a MND patient’s body deteriorates more and 
more, as they lose strength and start to find breathing more difficult. However, Fanos et al 
found no significant relationships between hope and forced vital capacity or between hope and 
individual as well as total ALSFRS-R scores.182 This could suggest that physical decline has a 
minor, if any, role to play in hope compared to other psychosocial factors. In a large group of 
adolescents, it was found that hope’s beneficial relation to anxiety (as well as depression, 
subjective happiness, and interpersonal difficulties) was mediated by attention to positive 
information.200 The authors suggested that this highlights both the importance of a hopeful 
thinking style, and attention to positive information, in the mental health of adolescents. It 
would be interesting to see whether similar associations could be found in patients with MND. 
Hope being significantly associated with anxiety is in accordance with other findings in adult 
mental health patients. Two measures of hope and one of hopelessness were found to 
significantly correlate with both state and trait anxiety, ranging from -.44 to -.67.201 
One study found that there was a significant interaction between loneliness and hope when 
predicting anxiety. The interaction was stronger for individuals with low hope compared to 
those with high hope.202 This highlights another way in which social factors may affect mood or 
psychological distress. 
Soundy et al’s suggestion that hope can be expressed as either a paradox, a dichotomy or as 
transcendence may go some way to explaining its effect on anxiety in MND.184 Transcendence 
based coping mechanisms such as meaning finding and biographical repair were found in 
narrative studies to be beneficial for MND patients, as a way of maintaining QOL and mental 
well-being.28,30 
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Definition of hope 
Studies must take care to be clear how they define hope. Hope can have a broad definition with 
many aspects to consider. A large survey of the general population found that ‘a religious sense 
of hope, but not a general sense of hope, reduces feelings of death anxiety across successively 
older age-groups’.203 Thus, it must be clear which aspects of hope are being considered, in which 
studies, to avoid overstating conclusions. Some earlier scales considered hope within the narrow 
conceptualisation of “an expectation of goal achievement” which is evidently inadequate. 
Qualitative work meant that later scales aimed to incorporate themes such as “the interpersonal 
element, the time-oriented, future focus of hope, and the goal-achievement expectation of 
hope”.195 Even further qualitative work meant that the Herth Hope Scale was based on Dufault 
and Martocchio’s204 model of hope in order to include elements of hope not included in the 
previous multidimensional measures such as “(a) a more global, non-time-oriented sense of 
hope, (b) hope despite diminished or absent interpersonal relationships, (c) hope as a sense of 
'being' available and engaging in relationships, as opposed to 'doing' for oneself and others, and 
(d) potential of hope for controlling behavioural or emotional responses as opposed to the 
control of events or expienences”.195 
Intervention for hopelessness 
Ganzini et al found that, in a population of MND patients, whilst hopelessness is a prevalent 
feature in depression, not all those who are hopeless are depressed.205 They suggested that, in 
the non-depressed group, it may be more appropriate to provide nonpharmacological 
interventions such as cognitive therapies, to reduce hopelessness, pessimism and any other 
form of existential despair. They suggested helping the patient to find meaning in the future, to 
reduce their fears and to avoid focusing on the worst possible outcomes. The idea of meaning 
finding being used to soothe existential worries again links to the theme of transcendence. 
Intervention for anxiety using hope 
The use of hope as an intervention was tested in a group of renal failure patients undergoing 
haemodialysis. The results showed that ‘hope therapy’ reduced depression and anxiety.206 
Another study examined using a hope-based intervention for patients undergoing genetic tests 
for hereditary colorectal cancer. Paired t-tests demonstrated a significant increase in hope post 
intervention, and a significant decrease in anxiety.207 
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Locus of Control 
A key theme of the reality-matching hypothesis (AKA goodness-of-fit hypothesis) is that of 
controllability and the appraisal of controllability. This is of interest in MND as its progression is 
not truly controllable (despite riluzole’s moderate effect), and the management of symptoms is 
similarly unwieldy.  
Affleck et al examined a cohort of rheumatoid arthritis sufferers and found that, in patients with 
moderate and severe disease, perceiving personal control over symptoms was associated with a 
more positive mood state, but that, in severe disease, perceiving personal control over the 
disease course was negatively associated with mood.208 This illustrates that a distinction must be 
drawn between control over symptoms and control over disease course, as these have different 
levels of controllability, and so perceived control has a different impact depending on which is 
considered, as per the goodness of fit hypothesis. The second consideration is that illness 
severity has an impact on the effect of perceiving personal control. 
This suggests that the study method used to examine locus of control in this MND cohort was 
too simplistic, as a relationship with anxiety was searched for without determining illness 
severity, and without making a distinction between symptoms and overall disease course. 
There may also be a substantial difference from the above study, in that rheumatoid arthritis is 
a chronic disease, as opposed to the inevitably fatal nature of MND. 
Multiple sclerosis (MS) is like MND in that treatment (and therefore controllability) is limited, 
but MS is complicated by its unpredictability, that results in a range from benign to severely 
disabling MS. It is also not inevitably fatal, as is seen with MND. This notwithstanding, research 
has found that low levels of controllability in MS moderate the effects of optimism on mood. 
There is also the suggestion that disability moderates the effect of locus of control on QOL: for 
less disabled patients, a highly rated internal LOC was beneficial, but in severely disabled 
patients greater internal LOC was associated with poorer QOL.209 This further supports the 
consideration of additional factors when examining the effects of LOC, in this case disability. 
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In their paper on HIV-positive men, Park et al mention earlier work suggesting styles of coping to 
be a significant co-variable, when assessing controllability and how appraisal of controllability 
affects adjustment.210 They mention that in general, problem-focused coping has been 
associated with better adjustment than emotion-focused coping, however they point out that 
better adjustment can be seen with problem-focused coping when faced with controllable 
situations, and better adjustment can be seen with emotion-focused coping in uncontrollable 
situations. Some studies mentioned by Park et al support the first statement but not the latter 
leading to the suggestion that “coping may be related to adjustment exclusively in controllable 
situations.” Park et al did in fact find that emotion-focused coping was more useful in situations 
appraised to be less controllable when compared to emotion-focused coping in controllable 
situations and so supported both suggestions. They attempt to explain the difference in their 
findings compared to others, by pointing out the differences in how emotion-focused coping is 
operationalised – in their case using ‘distancing’, a more neutral term than ‘self-denigration’ or 
‘escapism’ as used by other studies. A paper examining coping in MND found that patients rated 
both emotion-focused and problem-focused coping highly, but that they dealt better with the 
situation by utilising emotion-focused coping.49 
Park et al did clearly find support for problem-focused coping being beneficial in controllable 
situations, but, more relevant to MND, also found that meaning-focused coping (in the form of 
transcendence) was inversely related to depressed mood regardless of controllability.210 
Future work on LOC in MND should examine the relative use of problem, emotion and meaning-
focused coping as part of the analysis. 
Some criticism of the MHLC scales is the generality of the scales and the argument that patients 
may feel that they have different levels of control for different aspects of their disease.209 This is 
mentioned earlier in terms of the distinction between control over symptoms and control over 
disease course, but there may also be significant differences in controllability and perceived 
control between different symptoms, for example between pain and communication. Without 
asking separately about these specific aspects, the scale may not be nuanced enough, but it 
should also be noted that some symptoms are disease specific, such that to be comprehensive 
would require modified scales for each disease. This may not be feasible and so a balance must 
be struck between generality for applicability’s sake and specificity for accuracy’s sake. 
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This may go some way to explaining why self-efficacy is considered by some to be a better 
construct for explaining behavioural differences, as there are not as many distinctions to make, 
so that its generality is an advantage. The other point made by Luszcynska and Schwarzer is that 
MHLC is simply an attribution of responsibility, whereas self-efficacy is of prospective and 
operative nature.209 
There may be additional benefit (when examining LOC) in looking at combinations of the three 
subscores, as well as considering them separately. A paper on diabetes found that 2 
combinations, ‘pure internal’ (high internal score, low powerful others score and low chance 
score) and ‘believers in control’ (high internal score, high powerful others score and low chance 
score), had lower HbA1c values, postulated to be due to better adherence to self-care, than all 
other combinations of control beliefs.211 This is of interest because it appears that high ‘internal’ 
score may have had a permissive effect on whether a high ‘powerful others’ score had a 
significant effect. This makes sense in this example as it related to a self-care regime, so an 
individual who believed it was in their control to adhere to their doctor’s advice will do better 
than one who believes that their doctor has control over the disease but they do not. Again, in 
MND, specific symptoms and treatments would likely need to be considered separately, as some 
will be purely healthcare administered (e.g. botox injections for spasticity) and others will 
require input form the patient (e.g. managing a percutaneous endoscopic gastrostomy and diet). 
Management of MND is complicated and sometimes unreliable, and repeated treatment failures 
or difficulties may result in a loss of confidence in healthcare professionals’ and patients’ own 
ability to control their illness. This may then have further effects on ability to hope, optimism, 
mood and QOL. 
Ultimately all of the above should be taken into consideration when investigating locus of 
control in MND, but, due to time constraints and lack of skill, the methodology of this study was 
not able to be revised. 
Prevalence 
In this TONiC data (n=450) ‘probable’ anxiety as per the modified cut-offs was 13.5%. When 
scored in the non-modified HADS-A ‘probable’ anxiety was 13.8%. 
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Limitations 
Limitations include the reduction in cohort size due to elimination of participants with missing 
data for any of the factors investigated. Pertaining to this, the greatest number of missing data 
were from the Herth Hope Index, which, at nearly half of the original cohort, is likely to have had 
an effect on the results of this model. This may be due to difficulties with the scale itself – 
requiring a different, or at least modified, scale – or with the concept – requiring qualitative 
work to examine the issues around this and identify how this could be addressed. The three LOC 
subscales each had greater than 5% missing data and it seems evident that consideration of 
other factors alongside LOC would be required to examine this factor properly. 
The reduced cohort had greater than 10% differences from the original cohort in terms of ‘time 
from diagnosis’, onset type and employment status and it is possible that these could have had 
effects on participants’ experiences of either hope or LOC and so these may require further 
investigation before the results of this model can be fully interpreted. 
Conclusion 
This study lends support to hope being an important factor in patient’s experience of MND.  
Future research should consider further associations alongside transcendent coping 
mechanisms, such as meaning finding and reappraisal. LOC is worth further investigation, since 
this analysis did not consider other significant factors such as level of disability and coping styles. 
If these were considered this could result in subscales of locus of control having a significant 
relationship with anxiety. 
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Investigating Social Withdrawal in Motor 
Neuron Disease 
Introduction 
Importance of social factors and why? 
Social factors were found to be linked to GQOL in the systematic review. Social support was the 
third most examined factor in quantitative studies, with five quantitative studies, and social 
withdrawal and social isolation added three studies between them. In particular, Chio et al’s 
study found that, of the variables they measured, the most important explicatory variable for 
both the SEIQOL-DW and the MQOL was social support.20 Qualitative studies showed MND 
patient’s perspective changed such that “family and friends” drove patient’s meaning in life28, 
“family/significant other… friends… social life” affected their QOL16, and “the vital importance of 
interpersonal relationships” was a key theme in coping29. 
Investigating the domains of QOL would be of interest as it may be felt that social factors will 
have a strong relationship with the ‘social relationships’ domain and perhaps ‘psychological 
health’, but how it relates to ‘physical health’, and ‘environment and financial resources’ is less 
certain.  
One question might be whether social factors are so important in part due to the nature of 
MND. As the disease progressively reduces a person’s independence by reducing their physical 
strength, and isolates them by reducing their mobility and ability to communicate, is it better to 
share their burden and draw support from others rather than struggle and ultimately fail to be 
independent? Brownlee et al suggest that problems with adjustment may arise when a patient’s 
self-representation, for example as an independent person, conflicts with the disease-
representation, for example as severely disabling.212 They suggest that patients may create 
propositional rules (if…then…), such as “if I do not ask for help, then I am still independent”, but 
that these rules can lead to maladjustment, when the reality of the scenario does not allow for 
the rules to be followed without detriment to the patient’s life. 
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Because of a possible link with mobility, communication and independence, it will be of 
relevance to investigate the relationship of social withdrawal to ALSFRS-R domains. It is of 
particular interest as to whether increasing severity of bulbar and respiratory symptoms is 
associated with greater social withdrawal. 
For the above reasons, this thesis will examine social withdrawal in more detail. 
Methods 
Aim: To investigate Social withdrawal in this TONiC MND cohort. 
Research questions: 
1. What is the relationship between social withdrawal and the four domains of QOL as 
measured by the WHOQOL-BREF? 
2. Is Social withdrawal significantly associated with severity of ALSFRS-R domains? 
Analysis 
Initial plots did not suggest any non-linear relationships between the factors and social 
withdrawal, so multiple linear regression was chosen as an appropriate method. Single factor 
models were run initially, and then two multifactor models were created to investigate QOL 
domains and ALSFRS-R domains separately.  
Participants 
The data set was modified to produce two data sets such that for each multifactor model 
participants who are missing data for any of the factors to be examined were excluded from 
analysis for that multifactor model (WHOQOL-BREF domains model or ALSFRS-R domains 
model). This ensured uniformity of the population between the initial single factor models. 
Total participants: n = 465 
No missing data for social withdrawal and QOL domains: n = 417 
No missing data for social withdrawal and ALSFRS domains: n = 429 
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Scales 
o The WHOQOL-BREF is a 26-item short version of the original WHOQOL scale, which 
measures four domains of QOL: ‘physical health’, ‘psychological health’, ‘social 
relationships’, and ‘environment and financial resources’.213 
 
o The ALSFRS-R is a revised version of the ALSFRS, a tool for evaluating functional status. It 
has 12-items that make up three domains: ‘motor function’, ‘bulbar function’ and 
‘respiratory function’. These three domains will be used for analysis rather than a 
summed score for a number of reasons: By examining the domains, more information 
will be available about which domains may relate to social withdrawal and their relative 
importance when compared to each other, allowing for a determination of whether, for 
example, the severity of motor symptoms has a stronger association than the severity of 
respiratory symptoms. Additionally, it has been shown that the summed score of the 
ALSFRS-R does not stand up to rigorous psychometric testing as it is not unidimensional 
and so is not comparable between individuals with the same overall score.214 
 
o Social withdrawal was measured using the 14-item MND-SWS modified for use in MND 
as per the paper by Gibbons et al.120 
Models 
Single factor models were run for the following factors: 
 Physical health domain of WHOQOL-BREF 
 Psychological health domain of WHOQOL-BREF 
 Social relationships domain of WHOQOL-BREF 
 Environment and financial resources domain of WHOQOL-BREF 
 Physical health domain of ALSFRS-R 
 Psychological health domain of ALSFRS-R 
 Social relationships domain of ALSFRS-R 
 Environment domain of ALSFRS-R 
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Results 
 
  
QOL analysis 
All single factor models were significant. 
 Physical health  (F1,415 = 174.110, p < .001) 
 Psychological health (F1,415 = 95.221, p < .001) 
 Social relationships (F1,415 = 50.589, p < .001) 
 Environment  (F1,415 = 100.332, p < .001) 
The final model included the ‘physical health’ and ‘environment’ domains. The interaction 
term was not significant. The final model explained 31.1% of the variance in social 
withdrawal scores. 
 
R2 = .311 (F2,414 = 93.600, p < .001) 
The final model’s regression equation was as follows: 
MND-SWS = 66.446 – 1.612*physical health – 0.742*environment 
 
ALSFRS-R analysis 
All single factor models were significant. 
 Bulbar   (F1,427 = 12.144, p = .001) 
 Respiratory  (F1,427 = 23.379, p < .001) 
 Motor   (F1,427 = 96.759, p < .001) 
All factors were initially significant in the multifactor model but examination and removal of 
extreme cook’s distances (NOT(COO_1 > 0.08000)) resulted in ‘motor’ and ‘bulbar’ being the 
significant factors of the final model. The addition of the interaction factor motor*bulbar 
was not significant. The final model explained 30.7% of the variance in social withdrawal 
scores. 
R2 = .307 (F2,423 = 93.744, p < .001) 
The final model’s regression equation was as follows: 
 MND-SWS = 50.459 – 0.957*motor domain – 0.339*bulbar domain 
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Discussion 
Quality of life 
With regards to QOL domains, all single factor models were significant, suggesting that social 
withdrawal has a wider ranging relationship with QOL than just with social relationships and 
psychological health. When considered in the multi-factor model, the most parsimonious model 
included ‘physical health’ and ‘environment and financial resources’, which suggested that these 
were the most important domains of QOL with respect to social withdrawal and that together 
they explained 31.1% of the variance in social withdrawal scores. The order of importance of 
these domains as determined by their standardized coefficients was ‘physical health’, and then 
‘environment’ with coefficients of -0.442, -0.162 respectively. 
The analysis revealed that the four cases with the highest levels of social withdrawal did not 
follow the given trend for any of the QOL domains. These cases were not excluded, as to do so 
would falsely represent social withdrawal in this MND cohort. It is however likely that some 
additional factor may explain these outliers, and this could be the focus of future research. 
It is of note that ‘psychological health’ was of borderline significance. Considering the WHOQOL 
group’s comments in their psychometric paper using the general population that there was 
some cross-domain overlap between items in ‘physical health’ and ‘psychological health’215, it 
could be that this overlap was greater in our MND population, and that ‘physical health’ 
absorbed the explanatory power of ‘psychological health’, to the point of ‘psychological health’ 
not having a significant unique contribution. 
It may be considered surprising that the weakest relationship is between social withdrawal and 
the QOL domain 'social relationships'. However, the domain ‘social relationships’ encompasses a 
wide range of social factors including satisfaction with personal relationships, satisfaction with 
sex life, and satisfaction with support, whereas the ‘social withdrawal’ scale focusses on the 
ability to undertake and participate in social activities, as well as how being with others makes 
someone feel. Thus, the two measures are exploring different aspects of social relatedness. This 
may have contributed to the finding in this study that ‘social relationships’ had the most missing 
data out of the QOL domains, as a wider range of factors may have made it more difficult to 
answer all questions, especially considering attitudes to intimate questions around sex life. 
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In addition, the QOL domain ‘social relationships’ may be less reliable than other domains such 
as ‘physical health’ or ‘environment and financial resources’. In the psychometric analysis done 
by the WHOQOL group using a general population, it was found in 19 out of the 23 regions 
surveyed to have the lowest internal consistency of the four domains.215 When considering their 
total sample from all regions they reported Cronbach’s alpha for ‘social relationships’ to be 0.68 
compared to 0.82, 0.81 and 0.80 for ‘physical health’, ‘psychological health’ and ‘environment 
and financial resources’ respectively. The WHOQOL group described these findings as expected 
due to the low number of questions in the ‘social relationships’ domain, to which Cronbach’s 
alpha is sensitive. 
ALSFRS-R 
With regards to ALSFRS-R, all single factor models were significant demonstrating a link between 
physical function and social withdrawal. The most parsimonious multifactor model included the 
‘motor’ domain and ‘bulbar’ domain, suggesting these to be the most important ALSFRS-R 
domains when considering social withdrawal. The order of importance for ALSFRS-R domains 
was motor and then bulbar, as demonstrated by their standardized coefficients, -0.535 and -
0.113 respectively. These two domains explained 30.7% of the variance in social withdrawal 
scores. 
The association between motor and bulbar impairment and social withdrawal may be due to 
psychological distress occurring alongside declining physical function, but may also be to do with 
how these impairments impede participation in social situations. Declining motor function 
limiting mobility can impair an individual’s ability to leave their house and engage with others, 
especially without assistance or aids. Worsening bulbar disease can greatly limit communication 
without aids, as well as drooling and fear of choking possibly affecting patient’s decisions to 
engage in social activities such as eating in public. 
Increasing use of social media is an interesting factor that may have increasing relevance with 
regard to this, allowing easier contact with friends and loved ones.98 This contact can be made 
from afar, bypassing impaired mobility to some degree, although some may question to what 
degree online interactions can replace face-to-face interactions. 
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Social support is lauded in the literature but may not always be a good thing in and of itself, it 
may depend on context. Goldstein et al found that negative social support including negative 
interactions (as measured using the close persons questionnaire) predicted depression.82 
Context is also emphasised as important when considering Carver and Scheier’s theory of 
‘scaling back goals’ which involves shifting priorities.216 It was suggested that neither ‘scaling 
back goals’ nor response shift were helpful, if focus was directed at areas of their life that were 
in fact negative or unhelpful. An example being that emphasis on family would be helpful if the 
individual’s family was considered loving and warm, but that the same emphasis would be 
counterproductive when there was conflict in the family. 
Other factors and future research 
In Gibbons et al’s paper, fatigue and coping were seen to have significant effects on social 
withdrawal.23 Fatigue, as suggested for motor and bulbar symptoms, may exert an effect both 
psychologically and physically. It may decrease the desire to interact with others as well as limit 
the ability to interact with others. Care should be taken with assuming the direction of effect, 
especially with the measures of physical function, as a paper by Scharloo et al found seeking 
social support to predict better functioning in patients with psoriasis.217 The outcome measure 
used was however a measure of disability, so would not necessarily have discriminated between 
the impact of social support on the psychological burden of the illness and the purely physical. 
As this study evidences an association between social withdrawal and these symptoms, but via 
multiple possible mechanisms, it will be important to undertake qualitative studies such as semi-
structured interviews to better understand patient’s perspectives. 
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Another link between coping and social withdrawal was found in Hugel et al’s paper, which used 
structured interviews for physicians to independently assess whether they considered patients 
to be ‘copers’ or ‘non-copers’.218 Inter-rater agreement was excellent and ‘non-copers’ also had 
significantly lower scores on a self-completed coping scale. In the study, they found that ‘Non-
copers’ were significantly younger, had limb onset of disease, had significantly higher depression 
and anxiety scores and had significantly higher levels of social withdrawal at time point 1. This 
finding at time point 1 (T1) may indicate the increased importance of social factors early in the 
disease course as part of the initial adjustment to the diagnosis, and the importance of 
identifying these factors early in order to intervene and facilitate adjustment. The study also 
supports healthcare practitioners to have confidence in their ability to identify those individuals 
who are struggling to come to terms with their illness, and who may need additional support. 
Limitations 
Limitations include the reduction in cohort size due to elimination of participants with missing 
data for any of the factors investigated. In the QOL model, social relationships had greater than 
10% missing data. This, in combination with the possible issues with reliability discussed above, 
may have affected the result of this model. Also in the QOL model, there were greater than 10% 
differences from the original cohort with respect to marital status and employment status, both 
factors which could have had an effect on patients’ experience of social withdrawal, their rating 
of social relationships, their rating of their psychological health, or their rating of their 
‘environment and financial resources’. 
Conclusion  
The regression analysis reveals a significant relationship between social withdrawal and the four 
WHOQOL-BREF domains, notably with ‘physical health’, and ‘environment and financial 
resources’.  
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Social withdrawal also has a significant relationship with disease severity as demonstrated by 
significant single factor models for each of the domains ‘motor’, ‘bulbar’ and respiratory’. The 
multifactor model demonstrated the strongest associations with the ‘motor’ and ‘bulbar’ 
domains with multiple possible mechanisms for both of these factors being related to social 
withdrawal. Qualitative interviews could be used in a future investigation, to understand how 
social interaction is limited by the psychological and physical impact of increasing motor and 
bulbar symptom severity. 
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Investigating Global Quality of Life in 
Motor Neuron Disease 
Introduction 
Having examined depression, anxiety, and social withdrawal in more detail, it is worth re-
examining the findings of the systematic review for these factors, before evaluating their 
relationships with GQOL in this TONiC cohort. 
The systematic review identified 18 studies, which examined whether there is an association 
between depression and QOL. Some of these studies used multiple measures of depression and 
QOL, and so, in total, an association between depression and QOL has been examined 58 times. 
Depression had a significant negative correlation with QOL 37 times and was non-significant 21 
times. The studies used different methodologies, and some had low sample numbers, but 
overall indicate that there is a likely negative correlation between depression and QOL. For 
studies with participant numbers of 40 or under, table 1.0 shows their conflicting results. 
 
 
Study n Depression 
correlated with 
QOL 
Depression 
scale(s) 
QOL 
scale(s) 
Clarke et al - Assessing 
individual quality of 
life in amyotrophic 
lateral sclerosis.38 
21 No  HADS SEIQOL 
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Goldstein, Atkins, and 
Leigh - Correlates of 
Quality of Life in 
people with motor 
neuron disease 
(MND).43 
31 No  HADS SEIQOL-DW 
Lou et al - Fatigue and 
depression are 
associated with poor 
quality of life in ALS.47 
25 Yes  CES-D Psych 
wellbeing 
MQOL 
Lule et al - Depression 
and quality of life in 
patients with 
amyotrophic lateral 
sclerosis.48 
T1=39 
T2=30 
Yes  ADI-12 SEIQOL-DW 
Pizzimenti, Aragona, 
and Onesti - 
Depression, pain and 
quality of life in 
patients with 
amyotrophic lateral 
sclerosis: A cross-
sectional study. 57 
36 Yes  Zung self rating 
dep scale 
Spitzer 
QOL index 
Tramonti et al - 
Quality of life of 
patients with 
amyotrophic lateral 
sclerosis.62 
40 Yes ZDS Subscales 
of SF-36 
No ZDS SEIQOL 
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Winter et al - Health-
related quality of life 
in ALS, myasthenia 
gravis and 
facioscapulohumeral 
muscular dystrophy.64 
37 Yes  depression/anxiety 
domain of EQ-5D 
SF-36 
Mental 
component 
scale, EQ-
VAS 
No depression/anxiety 
domain of EQ-5D 
EQ-5D 
Table 6.1 Table to show the results of studies examining depression with participant numbers of 
40 or under. 
Of studies with over 100 participants, the two studies reporting definite associations were the 
largest (n = 964) and third largest (n = 147). McCabe et al also reported a definite yes but at a p-
value of p = .08 which would be considered by some to be non-significant or borderline. The 
second largest study, by Koerner et al, found mixed results when comparing the BDI, with and 
without somatic items, to subscales of the SF-36. BDI correlated with all domains except the 
‘physical functioning’ subscale and the BDI with somatic items removed correlated with ‘general 
health’, ‘vitality’, ‘social functioning’, ‘emotional role’, and ‘mental health’ subscales but not 
with ‘physical functioning’, ‘physical role’, or ‘bodily pain’. The study reporting a non-significant 
association was limited by its use of a 6-point scale for QOL. The sample size of the TONiC study 
is the second largest when compared to the studies identified in the systematic review but it is 
worth considering that the only study with a larger cohort used the EQ-5D, a HRQOL measure. 
Study n Depression 
correlated with QOL 
Depression 
scale(s) 
QOL scale(s) 
Ganzini, Johnston, 
and Hoffman - 
Correlates of 
suffering in 
amyotrophic lateral 
sclerosis.42 
100 No DSM-IV 6-point scale 
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Gibbons et al - The 
impact of fatigue and 
psychosocial 
variables on quality 
of life for patients 
with motor neuron 
disease.23 
147 Yes HADS-MND WHOQOL-
BREF 
Koerner et al - 
Interaction of 
physical function, 
quality of life and 
depression in 
Amyotrophic lateral 
sclerosis: 
characterization of a 
large patient 
cohort.46 
159 Mixed  
 
BDI Subscales of 
SF-36 
Mixed  BDI without 
somatic 
components 
Subscales of 
SF-36 
McCabe, Firth, and 
O’Connor - Mood and 
quality of life among 
people with 
progressive 
neurological 
illnesses.51 
120 Yes (but p = .08) POMS-SF WHOQOL-
BREF 
Thakore et al - 
Depression in ALS in a 
large self-reporting 
cohort.60 
964 Yes PHQ-9 EQ5D, EQ5D-
VAS 
Table 6.2 Table to show the results of studies examining depression with participant numbers of 
100 or over. 
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Of the thirteen studies examining depression that used GQOL measures, nine studies reported 
significant associations, three reported no significant associations and one study, using three 
QOL measures, reported mixed results. Interestingly the three studies reporting no association 
were using the SEIQOL and SEIQOL-DW as their measures of QOL. The SEIQOL has been 
described as limited in evaluating the QOL of groups and has been posited to measure a 
construct other than QOL.69 
 
Figure 6.1 Chart to show depression’s association with GQOL measures. 
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The systematic review identified seven studies which looked at the association between anxiety 
and QOL. Again, studies used different and sometimes multiple measures of anxiety and QOL. 
Five times there was a significant negative association and thirteen times the association was 
non-significant. Eleven out of thirteen of the non-significant results for anxiety were obtained 
when subscales of the SF-36 (HRQOL measure) were used. The five significant associations were 
found with WHOQOL-BREF, SEIQOL-DW, Endicott Quality of Life Enjoyment and Satisfaction 
Questionnaire, MQOL and the mental component score of the SF-12. The former four 
demonstrate anxiety’s association with GQOL and the latter is a mental health HRQOL measure. 
Significantly, when considering only GQOL measures, the ratio of significant to non-significant 
associations is 4:2. The anxiety measures for the studies with significant results were the POMS-
SF, HADS and STAI, the measure for the studies with non-significant results was the HADS. Thus, 
studies using HADS-A have reported conflicting results for HADS’ relationship with GQOL, this 
may be explained to some degree by the sample sizes. The two studies with non-significant 
results had the smallest sample sizes at 26 and 31 compared to 120, 75, 50 and 49.  
Study n Anxiety correlated 
with GQOL 
Anxiety 
scale(s) 
QOL scale(s) 
Clarke et al - 
Assessing individual 
quality of life in 
amyotrophic lateral 
sclerosis.38 
 
26 No HADS SEIQOL-Index 
Goldstein, Atkins, 
and Leigh -  
Correlates of Quality 
of Life in people with 
motor neuron 
disease (MND).43 
 
31 No HADS SEIQOL-DW 
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Rabkin, Wagner, and 
Del Bene - Resilience 
and distress among 
amyotrophic lateral 
sclerosis patients 
and caregivers.58 
 
49 Yes STAI Endicott 
Quality of Life 
Enjoyment 
and 
Satisfaction 
Questionnaire 
O’Doherty et al - 
Measuring life 
quality, physical 
function and 
psychological well-
being in neurological 
illness.54 
 
50 Yes HADS SEIQOL-DW, 
MCS SF-12 
Peric et al – Health-
related quality of life 
in patients with 
myotonic dystrophy 
type 1 and 
amyotrophic lateral 
sclerosis.56 
74 No Hamilton 
anxiety score 
Subscales of 
SF-36 
Vignola et al - 
Anxiety undermines 
quality of life in ALS 
patients and 
caregivers.63 
75 Yes STAI MQOL 
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McCabe, Firth, and 
O’Connor - Mood 
and quality of life 
among people with 
progressive 
neurological 
illnesses.51 
120 Yes POMS-SF WHOQOL-
BREF 
Table 6.3 Table to show the results of studies comparing anxiety and QOL in order of increasing 
participant numbers. 
Of the previous studies investigating anxiety, the greatest sample size was 120 participants; this 
study will examine this relationship using a sample size of 409. Investigating the impact of 
anxiety on a GQOL measure in a cohort of this size will add valuable data to the literature. 
Two studies examining the relationship between social withdrawal and QOL in MND were 
identified in the systematic review. Twice a significant correlation was found and two times the 
correlation was non-significant. All of the QOL measures were GQOL measures. Chio et al’s study 
examined three different GQOL scales and only found a significant association with the MQOL-
SIS, which may be seen as discouraging when considering that the MQOL-SIS was the least 
nuanced of the GQOL measures. As Simmons suggests, single question evaluations of QOL may 
not “provide the patient with a platform by which to perform a structured, item-by-item 
analysis of their QOL”.16 Of the related social factors support and isolation, support had six 
significant results and one non-significant result and isolation had one non-significant result. The 
term social isolation may be interchangeable with social withdrawal, but no formal definitions 
are given, and use of either term seems to be determined only by which measurement scale is 
used. For example, in the case of the ‘Nottingham Health Profile – Part 1’ (NHP-1) or the ‘Close 
Persons Questionnaire’, the term ‘social isolation’ is used and in the case of the ‘social 
withdrawal scale’ or ‘MND – social withdrawal scale’, social withdrawal is of course used. 
Although there appears to be no distinction, it is important that future researchers define what 
they are measuring clearly. 
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Study n Social 
Withdrawal 
correlated with 
GQOL 
Social 
Withdrawal 
scale(s) 
QOL scale(s) 
Gibbons et al - 
The impact of 
fatigue and 
psychosocial 
variables on 
quality of life for 
patients with 
motor neuron 
disease.23 
147 Yes SWS-MND WHOQOL-BREF 
Chio et al - A 
cross sectional 
study on 
determinants of 
quality of life in 
ALS.20 
80 No SWS-MND SEIQOL-DW 
No SWS-MND MQOL 
Yes SWS-MND MQOL-SIS 
Table 6.4 Table to show the results of studies comparing social withdrawal and QOL. 
The role of social factors in QOL is complex and not fully-understood but qualitative studies 
suggest that it is a promising avenue for research.  
Method 
Aim: To investigate the association between the three factors depression, anxiety and social 
withdrawal and GQOL in this TONiC MND cohort. 
Research questions: 
1. Does depression have a significant association with GQOL? 
2. Does anxiety have a significant association with GQOL? 
3. Does social withdrawal have a significant association with GQOL? 
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Analysis 
Initial plots did not suggest any non-linear relationships between the factors and WHOQOL-
BREF, so multiple linear regression was chosen as an appropriate method.  
Participants 
The data set was modified, such that participants who were missing data for any of the factors 
to be examined were excluded from all analysis. This ensures uniformity of the population 
between the initial single factor models. 
Total number of MND participants: n = 465 
No missing data for Overall QOL, depression, anxiety and social withdrawal: n = 409 
Scales 
o GQOL was measured using the total score for WHOQOL-BREF 2.0 calculated as 
described in the WHOQOL 2.0 handbook to be comparable to the WHOQOL-100.213 
 
o Depression was measured using the HADS-D subscale modified for use in MND as per 
the paper by Gibbons et al.119 
 
o Anxiety was measured using the HADS-A subscale modified for use in MND as per the 
paper by Gibbons et al.119 
 
o Social withdrawal was measured using the MND Social withdrawal scale (MND-SWS) as 
per the paper by Gibbons et al.120 
Models 
Single factor models were run for the following factors: 
 Depression 
 Anxiety 
 Social withdrawal 
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Results  
All single factor models were statistically significant when compared to the null model (all p < 
.001). 
A final model including the three factors and an interaction term was significant (F4,404 = 157.090, 
p < .001). The interaction term was between anxiety and social withdrawal, which suggests that 
the effects of anxiety and social withdrawal on QOL do not only depend on their respective 
coefficients but also on each other and the interaction coefficient. Interaction terms between 
‘depression and anxiety’, and ‘depression and social withdrawal’ were not significant. The final 
model accounted for 60.9% of the variance in WHOQOL 2.0 scores as shown by an R2 of 0.609. 
The final model’s regression equation was as follows: 
 
The interaction term was analysed graphically, as described in chapter two, by plotting social 
withdrawal against QOL, but with the data points for social withdrawal grouped by levels of 
anxiety.  
The findings indicated that greater anxiety at a set level of social withdrawal resulted in lower 
QOL but with this difference diminishing as social withdrawal increased. There was an intercept 
within the range of the TONiC data where, at a high level of social withdrawal, individuals with 
‘non-case’ level anxiety have worse predicted QOL compared to ‘possible’ anxiety. The 
interaction is commented on further in the discussion below. 
Discussion 
Significant factors 
Depression   (F1,407 =  132.557, p < .001) 
Anxiety   (F1,407 =  146.632, p < .001) 
Social withdrawal  (F1,407 =  158.561, p < .001) 
WHOQOL-BREF = 76.672 – 1.895*HADSDmod - 0.936*HADSAmod – 0.335*SWS + 
0.020*(HADSA*SWS) 
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These results show that for the TONIC cohort of the MND population, depression, anxiety, and 
social withdrawal are all statistically significant factors that combine to strongly influence a 
patient’s GQOL.  
This was shown by the single factor models (all p < .001) but also the final combined model 
which showed each factor having a unique contribution when considered alongside each other 
and with the final model explaining 60.9% of the variance in QOL scores. 
Each factor’s unique contribution meant that for example, even when a proportion of the 
variance in QOL has been explained by depression and social withdrawal, the addition of anxiety 
increases the explanatory power of the model with a significant change in the F statistic. The 
three factors’ order of importance, as determined by their standardised coefficients, was 
depression (-.554), followed by social withdrawal (-.408), followed by anxiety (-.359). 
Strengths of this study 
The use of measures which had undergone Rasch validation provided the benefit of robust 
interval scales for the independent variables. A large sample population meant that multiple 
factors could be entered into the regression model and be adequately powered, thus lowering 
the chances of noise (in the form of high standard deviation - σ), obscuring the relationship 
between variables and producing false negative results. 
In future, a comprehensive model considering all biopsychosocial factors and explaining close to 
all the variance in QOL scores may never be possible or even desirable. However, studies such as 
this may have separate merit by increasing awareness of factors and their relative contribution 
to QOL in MND, therefore influencing the thinking around MND and MND patient management.  
Generalizability 
This study supports the importance of these three factors in the United Kingdom MND 
population but further research may be required to confirm or deny the generalisability of these 
results to the global MND population, especially considering the impact cultural variation can 
have on certain psychosocial factors.219 This notwithstanding, it could be considered surprising 
for these three factors not to have an effect on QOL in other countries and cultures as they are 
ubiquitous and consistently carry negative connotations in terms of their effects. 
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Interaction between anxiety and social withdrawal 
Analysis of the interaction between social withdrawal and anxiety was done graphically by 
comparing regression lines for groupings of anxiety on a plot of social withdrawal versus QOL. 
This was first done by grouping anxiety as three equal sized groups and then repeated using the 
modified cut-off points as suggested by Gibbons et al119. It was deemed as part of the analysis 
that the cases with the 4 highest values for social withdrawal were exerting undue effect on the 
gradient of the regression lines and the differences are demonstrated in the ‘equal groups’ 
analysis (figure 6.2 compared to figure 6.3) as well as the ‘modified cut-offs’ analysis (figure 6.4 
compared to figure 6.5). The following discussion comments on the analyses in which those 
values were excluded (figures 6.3 and 6.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
118 
 
‘Equal groups’ 
 
Figure 6.2 Graph of the interaction term with all data points and anxiety grouped into equal 
sized groups. 
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Figure 6.3 Graph of the interaction term without 4 highest social withdrawal values and anxiety 
grouped into equal sized groups. 
Exploring the Interaction of social withdrawal with anxiety using the scatterplot shown in figure 
6.2 suggested that: for the range of results available, at a set level of social withdrawal, low 
anxiety resulted in higher QOL than moderate anxiety. This was also true of the relationship 
between moderate and high anxiety groups. However, the gradient of the line for low anxiety 
was steeper than for moderate anxiety which was in turn steeper than for high anxiety. This 
suggests that, as social withdrawal increases, the additive effect of higher levels of anxiety 
lessens.  
This interpretation is limited by the fact that the groupings of low, moderate and high anxiety 
are not based on any clinically meaningful cut-offs but were simply an even dividing of the 
ordered results into three groups. 
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‘Modified cut-offs’ 
The analysis of the interaction was repeated with the modified cut-off points as suggested by 
Gibbons et al119 which gave relative frequencies of 56 ‘probable’ cases, 56 ‘possible’ and 293 
non-cases.  
 
 
 
Figure 6.4 Graph of the interaction term with all data points and anxiety grouped using the 
modified cut-offs. 
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Figure 6.5 Graph of the interaction term without 4 highest social withdrawal values and anxiety 
grouped using the modified cut-offs. 
Examining figure 6.4 reveals similar findings to figure 6.2 with greater anxiety at a set level of 
social withdrawal resulting in lower QOL, with this difference diminishing as social withdrawal 
increases. There is an intercept within the range of the TONiC data where, at a high level of 
social withdrawal, individuals with ‘non-case’ level anxiety have worse predicted QOL, compared 
to ‘possible’ anxiety. 
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The interaction between anxiety and social withdrawal is difficult to interpret at high levels of 
withdrawal, and further research may help enlighten the true relationship between the 
variables. One possibility may be that not all social interaction is beneficial for MND patients, 
and it may be that in the case of highly anxious patients, increasing social withdrawal has less of 
an effect due to the lack of negative social experience, which may outweigh positive social 
experience in terms of effect on this subgroup of patients. Hogg, Goldstein and Leigh suggested 
that MND patients may find relating to other people anxiety provoking, because of the pattern 
of physical impairments that characterise MND.143 
A limitation of the analysis using the modified cut-offs may be that, with these smaller numbers 
in the ‘probable’ and ‘possible’ groups, the regression lines estimated by SPSS for these groups 
may be less accurate, when compared to the non-case group. 
Clinical Implications 
This study confirms the utility of healthcare personnel considering these psychosocial factors 
when managing and interacting with MND patients, and suggests the large benefit that could be 
gained from interventions aimed towards these three factors. Despite a lower prevalence than 
perhaps expected of psychiatrically defined anxiety and depression in MND populations74, 
reinforced by this study’s findings of low levels of ‘probable depression’ and ‘probable anxiety’ 
using the modified HADS, this analysis shows a significant association with GQOL along a 
continuum of depression and a continuum of anxiety. It may be that there is a substantial 
population of ‘sub-threshold’ depression and anxiety who would not be identified when 
examining prevalence of ‘depressive illness’ or ‘anxiety disorder’, but for whom their depressive 
and anxious symptoms have a significant impact on their QOL. Thus, a liaison service or 
increased availability of psychology and psychotherapy services may have a broader impact 
mitigating moderate levels of anxiety and depression (‘possible’ depression and anxiety 
measured via the HADS) and therefore reducing their effect on QOL. Social withdrawal could be 
targeted with support schemes as well as addressing their mobility and communication needs. 
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From the successful application of the multiple linear regression model, it may be hoped that in 
future a multifactor clinical tool, based on regression, may be developed to assist healthcare 
workers in assessing a patient’s QOL. This could increase efficiency with clinicians or other staff 
entering demographic data as well as information from a preclinic questionnaire to give an 
estimation of the patient’s QOL as well as flagging the relevant areas for discussion. 
However, a problem with this approach, as seen from the qualitative studies mentioned in 
chapter one, is that QOL has a very individual basis. A worry may be that healthcare 
practitioners over-relying on a tool as described above could limit the range of discussion, and 
may not accurately cover the issues pertinent to each individual. As a compromise, the use of 
pre-clinic questionnaires or online forms could help to stratify patient’s risk of depression, 
anxiety, social withdrawal, etc., and this could increase efficiency, by prompting whether it is 
appropriate to engage in a full clinical interview to investigate these areas.  
Limitations 
Limitations include the reduction in cohort size due to elimination of participants with missing 
data for any of the factors investigated. The measure for total QOL had greater than 10% 
missing data when compared to the original cohort. There was also a greater than 10% 
difference from the original cohort with respect to marital status and employment status and 
these could feasibly have had an impact on the factors examined here.  
This model sought only to examine these three factors’ relationships with GQOL, as directed by 
results of the systematic review. This is early work that could be improved on, and it is to be 
acknowledged that there is a plethora of other factors that are likely to have relationships with 
GQOL and these factors in turn could have affected the strength of the examined factors’ 
relationships with GQOL. 
Conclusion 
The results of this analysis suggest that the depression, anxiety, and social withdrawal do play a 
significant role with regards to MND patients’ QOL. The burden of depression and anxiety in this 
cohort in terms of prevalence of ‘probable depression’ and ‘probably anxiety’ may not be as 
high as expected for such a severe illness, but, when considering depression and anxiety on 
spectrums from symptoms into ‘illness’, the burden on the individual, in terms of QOL, is high. 
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This study supports the appropriateness of further in-depth investigation of these psychosocial 
factors, to understand factors affecting them, and to understand where interventions may be 
appropriate. The interaction between anxiety and social withdrawal warrants further study, to 
determine its true nature and what the implications of this may be. 
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Conclusions 
Conclusions of the chapters  
Systematic review 
The systematic review found that most studies focused on depression and anxiety and social 
factors relationship with QOL. This may be due to healthcare practitioners’ familiarity with these 
factors, especially depression and anxiety, where there is readily available information about 
diagnosis and management. This lends to the ease of investigation with regards to these factors, 
as well as increasing the likelihood that attention will be paid to the results of these studies; 
both themes increasing the incentive to study these factors compared to a wider range of 
psychosocial factors. 
Multiple tools are available for critical appraisal. Applying the STROBE checklist67 to ten 
quantitative studies suggested that improvements could be made by: clarifying the study design 
in the title or abstract; providing more detailed description of the setting of the studies, dates 
between which recruitment took place, and numbers of participants at each stage; describing 
how sample sizes were arrived at; and discussing the limitations of the studies and how 
potential bias may have affected the results. However, the findings of the limited analysis of ten 
studies should be interpreted with caution. 
Using the CASP checklist for qualitative studies65 it appeared that the qualitative studies 
identified by the review could be improved by more closely examining the relationship between 
the researcher and participants and how this may influence their results, as well as explicitly 
justifying their study design, recruitment strategy, and data collection. 
Unfortunately, multiple measures were used for QOL, HRQOL, as well as psychosocial factors. 
The resulting heterogeneity prevented any useful meta-analysis. This, in combination with the 
varying quality of the studies, resulted in inconclusive findings with respect to many factors and 
demonstrates the need for clearly oriented research – with respect to the findings of the current 
literature and their suggestions for future research – limiting itself to validated measures in 
order to provide a robust evidence base. 
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Depression 
Demographic factors did not have a significant association with depression in this study, but 
other studies are not agreed on this, so further investigation could be used to clarify this 
issue.140,141 It should also be considered that the demographics of this multifactor model, with 
depression as the outcome, were different from the ‘original’ n=465 cohort (see table 2.1), and 
this could feasibly have affected the results of this model. 
Similarly, time from diagnosis was not found to be significant in this study, but this relationship 
is compounded by so many possible factors that more sophisticated analysis is required. One 
possible interaction with time which was examined, was the interaction between time and 
disability – which was not significant in this cohort. 
The results of the single factor models suggested that all the domains of the WHODAS had a 
significant association with depression. However, the final model emphasised that domains six, 
four, and one had the strongest associations. These were ‘participation in society’, ‘getting along 
with people’, and ‘understanding and communicating’, which emphasised that the strongest 
associations were with social disability.  
Physical function may have other mechanisms by which it relates to depression, such as its 
impact on perceived health85, and this may warrant investigation following on from the theme 
‘the importance of subjectivity’ discussed in this thesis. 
Reviewing the literature, treatment for depression in MND seems to be based on general 
guidelines for depression in chronic illness.167 Some studies suggest that this may not be entirely 
appropriate168, and there is a call for MND specific studies, to develop or determine useful 
interventions.173 
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Anxiety 
Hope was found to have a significant association with anxiety. The definition of hope in MND 
must be considered to be more than just a ‘hope for cure’, incorporating many other categories 
including ‘social support’, ‘search for information’, ‘spiritual beliefs’, ‘limiting the impact’, 
‘adapting to changing capacities’, ‘living in the moment’, and ‘self-transcendence’.182 This is 
important because of the links to transcendence, which is an area of study with great potential 
benefits for MND patients, and because of how it demonstrates that the idea of hope and the 
act of hoping is very individual and can vary greatly amongst patients. This again challenges 
preconceived notions of disease and illness and emphasises the disparity between what 
professionals and laymen alike may think and how patients actually experience their illness.  
None of the locus of control subscales were found to have a significant association with anxiety, 
but in retrospect the study design was deemed inadequate, as it did not specify whether the 
locus of control was with respect to overall disease course or symptoms, and did not consider 
the impact of differing levels of disability, and different coping strategies. Overall, the generality 
of this study does not consider many nuances that impact on the relationship LOC may have 
with mood and mental health based outcomes, and so future studies should consider other 
factors alongside locus of control. Alternatively, one may wish to examine a different construct 
instead of locus of control, one that is less dependent on as many external factors. One example 
would be self-efficacy, which is considered by Luszcunska and Schwarzer209 to be a superior 
construct for explaining behavioural differences. Explaining behavioural differences was not the 
goal of this study but it could also be considered that self-efficacy more closely relates to the 
‘self’ than LOC and so, as well as being easier to investigate when compared to the context 
specific nature of LOC, it is also in keeping with the emphasis on the importance of the 
subjective experience of patients. 
Social withdrawal 
To examine social withdrawal two multifactor models were created; one to examine 
associations with the 4 WHOQOL-BREF domains and one to examine associations with ratings of 
physical function as measured by the ALSFRS-R. 
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Single factor models found significant relationships between social withdrawal and the four 
WHOQOL-BREF domains. When considered in the multi-factor model, the most parsimonious 
model included ‘physical health’ and ‘environment and financial resources’. ‘Psychological 
health’ was borderline significant in the multifactor model and one reason for this may have 
been cross-domain overlap between ‘physical health’ and ‘psychological health’, similar to that 
found by the WHOQOL group in the general population.215 The finding that the weakest 
association was between social withdrawal and the ‘social relationships’ domain may be 
explained by the WHOQOL group’s finding that Cronbach’s alpha, and therefore reliability, was 
lowest for the ‘social relationships’ domain215, as well as the consideration that ‘social 
relationships’ considers a lot of other social aspects compared to just social withdrawal, possibly 
reducing the level of agreement between the two factors. 
With regards to the ALSFRS-R domains, social withdrawal had a significant relationship with 
each of the ‘motor’, ‘bulbar’, and ‘respiratory’ domains, as demonstrated by significant single 
factor models. 
The multifactor model demonstrated the strongest associations being with the ‘motor’ and 
‘bulbar’ domains, with possible mechanisms being psychological distress occurring alongside 
declining physical function, as well as how these impairments may impede participation in social 
situations. Declining motor function can greatly limit mobility, which therefore reduces an 
individual’s ability to leave their house and engage with others, without assistive devices or 
without the assistance of others. Declining bulbar function can isolate individuals by limiting 
communication as well as possibly increasing stigma associated with drooling, and possibly 
increasing fear of choking preventing “eating out” as a social activity. 
It could be considered that these two models may demonstrate how a large proportion of social 
withdrawal is driven by barriers to participation, in the form of poor health, and then, whether 
an individual has the financial and environmental resources to overcome the limitations 
imposed by their health. This may suggest that socioeconomic inequalities have a role to play in 
how MND patients experience social withdrawal. 
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Quality of life 
The overall QOL model showed that the three factors depression, anxiety and social withdrawal 
had significant associations with GQOL. These three factors explained 60.9% of the variance in 
WHOQOL-BREF, demonstrating the importance of psychosocial factors with respect to QOL. The 
order of importance of the factors, as determined by their standardised coefficients, was: 
depression, then social withdrawal, then anxiety. 
The major benefit of this study’s investigation of these factors when compared to the studies 
identified in the systematic review is the large sample size of 409 with the second largest sample 
size of studies examining depression, the largest compared to studies examining anxiety and the 
largest compared to the studies of social withdrawal and social isolation. 
A significant interaction term was found to exist between anxiety and social withdrawal, such 
that, for a set level of social withdrawal, a higher grouping of anxiety (using the modified HADS-
A) resulted in higher QOL. However, this difference between groups diminished as social 
withdrawal increased. The coefficient for this interaction term was small but possible reasons 
for its significance include the idea that not all social interaction is beneficial for patients with 
MND.143 
How these models’ methods build on the current literature and their drawbacks 
The systematic review identified that previous studies used a multitude of scales, sometimes not 
validated for use in research, and that this caused difficulty interpreting the results in a cohesive 
manner. Particularly, previous studies used multiple measures for QOL, including HRQOL 
measures, despite GQOL measures being shown to be superior for understanding the subjective 
experiences of MND patients. This thesis attempts to improve on that issue by using validated 
scales that are thought to be appropriate for the research questions being asked, and, with 
particular respect to QOL, by using a well-validated measure of GQOL. Additionally, previous 
work was often in the form of smaller studies for many of the factors to be investigated, 
whereas this thesis has a large cohort, with the largest multifactor model using data from 429 
participants, and the smallest multifactor model using data from 224 participants. With these 
considerations in mind, it is hoped that this thesis has helped to add clarity with regards to 
which psychosocial factors are associated with one another and with GQOL. 
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As part of the model building method of this thesis, participants with missing data for any of the 
factors to be examined in a multifactor model were excluded from analysis for that model. This 
was required because it would be disingenuous to rank factors’ order of entry into the model 
using their F statistic if those F statistics were drawn from different cohorts. This resulted in five 
unique cohorts of varying sizes, one for each multifactor model. 
Each of these models was designed to answer the research questions asked of it without 
consideration of the factors examined in the other models. Due to the model building approach 
chosen, a model incorporating all of the factors examined in this thesis would require exclusion 
of so many participants that it would result in it being under-powered. 
Because of the differences in the cohorts outlined in table 2.1, direct comparisons between 
multifactor models are unlikely to be valid. However, none of the cohorts vary so drastically that 
the general interpretation of their results, such as social withdrawal possibly being driven by a 
lack of resources, could not be investigated in conjunction with an interpretation from another 
model – for example, whether increasing resource provision may be associated with a decrease 
in social withdrawal, and thereby a decrease in social disability, and a lessening of depressive 
symptoms. 
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Overall 
The overall findings as described above are shown in figure 7.1. 
 
Figure 7.1 Diagram to show factors with significant associations (green) and non-significant 
associations (orange). Note that the arrows do not denote causality, only which factors were 
considered in relation to each other. 
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Clinical implications  
These findings are important, because understanding these factors’ relationships to each other, 
and to patients’ QOL, will allow targeted interventions as well as early identification of patients 
at risk for depression, anxiety and social withdrawal. This could mean, for example, targeting 
social disability to reduce depression or using low motor or bulbar ALSFRS-R scores to prompt 
questions about social withdrawal. 
Using social support groups to improve social disability may be problematic, due to issues with 
how these groups are perceived, as well as the difficulty of spending time with peers who may 
be further in their disease progression. Another way of improving patients’ ability to participate 
in social settings may be by improving their mobility, with mobility aids such as power assisted 
wheelchairs or by improving their communication, with augmentative and alternative 
communication methods such as alphabet boards, eye gaze technology or ‘electronic voice to 
output typed text’ devices. This links to the findings in chapter five which found that social 
withdrawal was associated with severity of motor and bulbar symptoms as well as finding that, 
out of the four GQOL domains the strongest associations with social withdrawal were from the 
‘physical health’ domain and the ‘environment and financial resources’ domain. An interesting 
avenue of research is the use of online social media, which may help patients remain connected 
to their close friends and relatives, but could also be adapted for use as a proxy for support 
groups. This could reduce material costs of running the support groups, due to not requiring a 
venue to be hired, or other amenities be provided, or someone being present to chair and run 
the group (someone could instead moderate the group remotely). Additionally, it may also 
remove the pressure of being directly confronted with one’s peers. A drop-out, drop-in style 
service could then be possible due to the lower material costs which may then allow patients to 
utilise the support group only when it would be advantageous for them, avoiding the possible 
negative consequences discussed by Locock and Brown171 in terms of distressing social 
comparison and disruption to identity. Improving patients’ autonomy may increase the value of 
this support as patients’ involvement can reflect their need at a specific point in time. 
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When considering the findings in relation to depression and anxiety in this study, one must bear 
in mind that interval scales and inferential statistical techniques were used. This means that 
depression and anxiety were not considered as groups of ‘cases’ and ‘non-cases’, or as 
‘probable’ depression/anxiety, ‘possible’ depression/anxiety and ‘non’ depression/anxiety, but 
were considered along a spectrum. This means that the findings of this study cannot be applied 
selectively to ‘diagnosed’ depression and anxiety, rather that they apply to MND patients as a 
whole. It is worth considering that there may be a substantial population of ‘sub-threshold’ 
depression and ‘sub-threshold’ anxiety, who may benefit from nonpharmacological 
intervention. 
Future research 
Considering that MND patients’ QOL has been found to be better than some would suspect24,25 
along with low levels of depression, some may wonder whether these patients are in denial and 
this is supported to some degree.220 However, this would ignore the findings suggesting that 
transcendence and response shift is important for maintaining patients’ psychological and 
existential well-being, which in turn preserves their GQOL.28–30 
One may also consider biological reasons for the findings of preserved QOL, such as cognitive 
impairment14,221 resulting in better QOL than expected, and relative preservation of the 
serotonergic system resulting in lower levels of depression220, but even if these were found to 
account for some of the picture, the importance of the psychosocial factors described above 
should not be overlooked. 
Another hypothesis for the better than expected QOL in MND could be framed in Carver and 
Scheier’s “scaling back goals” and “self-adjustment” model as they applied it to various 
diseases.216 This could be relevant in MND in that it may be that the daily experience and 
limitations of the disease – preventing patients from achieving their goals – creates a negative 
‘affect’, via the ‘feeling’ feedback loop,  that then drives an increase in the rate of adjustment in 
the ‘behaviour’ loop, an increase in psychological “velocity”. Thus, it could be that MND patients 
may more readily “scale back” their goals when compared to other disease groups, increasing 
the likelihood of ‘success’ and allowing them to remain engaged. Qualitative studies may help 
with understanding the validity of this argument. 
134 
 
Although the adjustment discussed in this thesis is mostly discussed with respect to ‘individual’ 
factors, a consideration should be made for the attitudes of others, in that, for the most part, 
society’s attitude toward illness is one that expects care and support to be given - proportional 
to the severity of the disease. Social support has been found to be an important factor and it 
may be that these societal attitudes or expectations could result in large support for MND 
patients (a severe illness) – a motivation which could be examined in qualitative studies with 
caregivers – and this may aid in the rapidity of adjustment. 
From all of the above said the evidence suggests that MND can drive positive growth of an 
individual. This links to themes explored by by Havi Carel in her consideration of the philosophy 
of medicine and illness.222–224 She talks about ‘wellness within illness’ and how severely 
chronically ill people are not necessarily committed to a life of misery. 
An overall limitation of this thesis is that due to the use of cross-sectional data the direction of 
effect between factors cannot be identified. This prompts the requirement of longitudinal 
studies. However, repeated measurement of psychosocial factors over time may be complicated 
by the ideas proposed by Golembiewski et al.225 
Golembiewski et al suggest that one must consider whether changes (or lack of changes) seen 
with repeated use of a scale is due to ‘true’ change where the meaning of the scale has not 
changed for the individual between measurements (termed alpha change). Alternatively, a 
change (or lack of change) can be due to the scale’s intervals no longer having the same 
psychological anchors as they did before (beta change), or due to an entire reconceptualization 
of that factor (gamma change). Howard et al link this conceptualisation of change to response 
shift and QOL, emphasising its relevance in this area.226 Another complication of longitudinal 
studies is of course the attrition rate associated with MND, but it is hoped that larger, multi 
centre studies, similar to the TONiC study, will help to produce robust results. Studies collecting 
large amounts of data from patients over time must be aware of the burden that can be caused 
by long, time-consuming questionnaire packs and difficult to use scales. Because of the disability 
and fatigue associated with MND, it is key to ensure that scales and questionnaires are 
acceptable to the patients, in order to avoid deterring them from continuing to participate in 
the study, or in future studies. 
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Considering the possibility of change in importance of psychosocial factors over time, further 
research should examine when certain factors are more important than others for maintaining a 
patient’s psychological well-being over time, and whether this compensates for other factors, 
such as declining physical ability. From this it can be seen that an additional benefit of 
longitudinal studies will be to plot the disease course with respect to psychosocial factors, 
exposing times of vulnerability, and times of improvement.  
Qualitative methodology should not be overlooked as this may help to suggest how and why 
certain factors are related, as well as suggesting which factors should be examined. An example 
of the former would be that, following this study’s findings of significant associations between 
the domains of ALSFRS-R and social withdrawal, structured interviews could be used to examine 
the mechanisms by which these relationships exist. An example of using qualitative studies to 
guide further study would be to focus on themes identified by patients as important, such as 
control, dignity and identity41, as well as worries about dependency44. 
Overall 
It is clear that considering psychosocial factors is key when trying to understand the experience 
of MND patients, what is important for their GQOL, and how to improve their care. Further 
research should seek to find further associations, using quantitative methods, and to 
understand how these associations may come about, using qualitative methods. Longitudinal 
studies are needed to understand the relevance of psychosocial factors throughout the course 
of the illness. 
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